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Introduction
1
Changes in global demographics have resulted in an increase in life expectancy, both 
in western populations and in populations in low and middle-income countries.1 As 
people age, most will develop some degree of cognitive deterioration, probably due to 
the accumulation of diseases and subclinical biological changes and damage.2 Indeed, 
with increasing life expectancy, cognitive decline became a major public health prob-
lem. The degree of age-related cognitive decline partly depends upon early cognitive 
development.3 Despite the recognition that cognitive decline may be determined by 
early childhood cognitive development itself or by common risk or vulnerability fac-
tors, clinical research rarely focuses on how to determine and optimize the factors that 
constitute cognitive development in early life. Rather clinicians focus on preventing or, 
most commonly, try to treat risk factors that affect loss of cognitive function in late life. 
Against this background, further studies of environmental and pathophysiologic risk 
factors that are associated with cognition in young age as well as with cognition and 
survival in old age on a population level are needed.4,5
One way of approaching healthy cognitive ageing is to determine developmental 
factors in early life that can affect cognition later in life. We know that the develop-
ment of cognitive function is influenced by many modifiable environmental factors.6 
A particular focus of infant research has been on the primary mode of nutrition i.e. 
breastfeeding. Breastfeeding has been linked to influence cognitive outcomes later in 
life.7 From a biological point of view, several aspects of breastfeeding such as duration, 
exclusivity, and constitutional elements have been hypothesized to have influence on 
cognitive development of children.8 Many other factors such as maternal IQ and socio-
demographic status, however, have also been linked to both breastfeeding during 
infancy and cognitive function in childhood.9 Previous lines of literature have reported 
mixed findings regarding the associations between breastfeeding with child cognitive 
outcomes.7-9 Therefore, we aimed to investigate the associations between breastfeeding 
and child cognition in a large 21st century cohort study that generated prospectively 
collected breastfeeding data along with a variety of confounding variables that would 
reduce potential bias among these associations.
It is also hypothesized and demonstrated that the origins of cardiovascular diseases 
start early in life.10 The accumulation of risk factors throughout the life course most prob-
ably predisposes to disease processes that lead to cognitive functional decline in old 
age.11 Therefore, we investigated the associations between cardiovascular risk factors 
and cognition early in life as well as in old age. In two population-based cohorts, we tried 
to decipher whether the onset of cognitive decline may have early childhood origins.
A second radical approach to healthy cognitive function in old age is to determine 
the effect of different subjective measures on diseases that affect cognition. In clinical 
research, the use of subjectively assessed measures that may be predictive of health, 
onset of disease and survival remains largely unexplored.12 Against the background of 
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the many acclaimed biomarkers studied in blood, tissue, imaging or genetic material, 
we studied subjective measures that may predict health outcomes. Subjective well-
being may help disentangle the factors that affect health across the lifespan. In this 
context, we aimed to determine the association of self-reported variables on stroke and 
mortality .
A third approach to decipher factors related to healthy cognitive ageing is to system-
atically review existing body of literature. Such reviews can inform both practice and 
future research and may help identify gaps in literature and address areas where further 
research is needed. Throughout the available literature, there is a lack of consensus on 
certain epidemiological aspects of cognition in old age that makes it difficult to gener-
alize findings of individual studies. One example is the concept of “cognitive reserve”. 
Cognitive reserve is a phenomenon that determines the extent of pre-morbid intel-
ligence. This reserve makes the cognitive functioning of some persons more resilient 
than others to disease.13 Thus, we aimed to explore previous lines of literature on the 
assessment or measurement of cognitive reserve to reach a consensus on its operation-
alization in the general population. Another area of research that lacks consensus is the 
methodology used across published studies to estimate the burden of stroke in low- 
and middle-income countries.14 Thus there is a need to accurately estimate the burden 
of stroke and establish standardized disease surveillance systems in order to implement 
preventive and rehabilitative strategies in these resource-poor settings.
AIMS Of THIS THESIS
The aims of this thesis are two-fold: 1) to extend existing knowledge on determinants 
of cognition in early life; 2) to determine factors that affect cognition and survival in 
late-life.
The studies presented in this thesis are imbedded within two population-based pro-
spective studies in Rotterdam, the Netherlands. For research questions regarding the 
first aim, we used data from the Generation R Study,15 a child cohort from foetal life 
onwards. To meet the second aim, we used data from the Rotterdam Study,16 a cohort 
study among people of 45 years and older in the district of Ommoord.
15
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OUTlInE Of THIS THESIS
In chapter 2.1, we investigate the association of breastfeeding duration and exclusiv-
ity with non-verbal IQ in children. In chapter 2.2, we explore whether arterial stiffness 
measured by carotid-femoral pulse wave velocity can affect child IQ or general cogni-
tion in an elderly population. In chapter 3.1 we study subjective indicators of health 
and well-being as predictors of all-cause mortality among the elderly. In chapter 3.2 
we investigate the relation between subjective complaints about memory and incident 
stroke and whether these associations depend on the level of education. In chapter 4.1 
we systematically review reviews published on the concept of cognitive reserve and its 
operationalisation in the general population. In chapter 4.2 we review and meta-analyse 
previous literature determining the incidence rate of stroke in low-and middle-income 
countries. In chapter 5, the main findings of these studies are discussed, together with 
their methodological considerations, clinical implications and future directions for 
research.
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ABSTRACT
Background Breastfeeding has been related to better cognitive development in chil-
dren. However, due to methodological challenges such as confounding, recall bias or 
insufficient power, the mechanism and nature of the relation remains subject to debate.
Methods We included 3761 participants of a population-based cohort study from fetal 
life onwards and examined the association of breastfeeding duration (exclusive and par-
tial continuously and in categorical-two month bands) with non-verbal intelligence in 
children of age 6 years. Maternal and paternal lifestyle, sociodemographic factors, child 
factors, and maternal IQ were tested for their confounding effects on the association.
Results We observed an initial association between breastfeeding duration and child IQ 
conferring an advantage of 0.32 (95% CI 0.20 - 0.44) points for each additional month of 
breastfeeding. This association strongly attenuated to 0.09 (95% CI -0.03 - 0.21) points 
after adjustment for child factors, socio-demographic factors, parental lifestyle factors, 
and maternal IQ. Similarly, the associations with breastfeeding duration as a categorical 
variable largely disappeared after confounding factors were added to the models.
Conclusions The association between breastfeeding and child IQ can be largely ex-
plained by sociodemographic factors, parental lifestyle and maternal IQ. Our results 
cannot confirm beneficial effects of breastfeeding on child intelligence.
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InTRODUCTIOn
The World Health Organization (WHO) recommends six months of exclusive breastfeed-
ing followed by partial breastfeeding until age two years for overall healthy growth and 
development of children.6 The scientific evidence on the long-term benefits of breast-
feeding for child cognitive development, however, offers mixed support and is still a 
subject of debate.
Several observational studies showed positive effects of breastfeeding on child 
IQ,7,18-26 whereas others concluded that breastfeeding is a proxy for parenting and 
other cognitive factors in the home environment instead of a causal factor in itself.27-32 
However, the majority of published articles have important methodological issues, such 
as retrospective data collection of breastfeeding, risk of misclassification bias by mea-
suring breastfeeding as a dichotomous variable (ever vs. never), small sample sizes or 
insufficient adjustment for critical potential confounders, of which maternal IQ is most 
important. The large cluster-randomized trial on breastfeeding promotion (PROBIT), 
which by design minimized effects of confounding, also found significant differences 
between the intervention group and the control group.33 However, information bias 
due to non-blinding of clinicians assessing the cognitive outcomes is plausible and 
exclusion of mothers who decided not to initiate breastfeeding prior to trial inclusion 
limit generalizability to Western countries. Moreover, due to ethical constraints, this trial 
could only study the effect of a promoting intervention instead of measuring the effects 
of breastfeeding itself. Therefore, cognitive effects between groups could be driven by 
other factors, such as increased self-confidence and better sensitivity to infant cues in 
young mothers who received additional information in the early postpartum period.34,35
The hypothesized underlying mechanism to explain the association between breast-
feeding and child intelligence centers around the biological components in breast milk, 
such as essential long-chain polyunsaturated fatty acids (LCPUFAs).36 These LCPUFAs 
have been linked to optimal neurodevelopment in infancy due to accumulation in the 
cell membranes of the neurons.37 Following this research, formula feeding is increasingly 
being fortified with LCPUFAs since the late 90s. One could hypothesize that the benefits 
for child cognition are less clear in studies performed afterwards, although randomized 
controlled trials did not find clear effects of supplementation on neurodevelopment in 
term infants.38,39
To fully address the subtle effects of breastfeeding on child IQ, there is a continuing 
need of large studies with sufficient power, prospective collection of breastfeeding data, 
including quantification of breastfeeding duration and exclusivity to allow detection 
of dose-response relationships, as well as data collection on important confounding 
variables including maternal IQ. Within the Generation R Study, a prospective pop-
ulation-based study from fetal life onwards, we aimed to further investigate whether 
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breastfeeding duration (either exclusive or partial) was associated with child cognitive 
development. This study was performed in a transition period of LCPUFAs fortification, 
in which about 50% of formulas were fortified. Participants in our study show high vari-
ability in ethnic background, which is why we focused on non-verbal intelligence. We 
hypothesized significant attenuation of the effect of breastfeeding on child non-verbal 
intelligence by confounding factors, most notably by maternal IQ.
METHODS
Study population
This study used data from the Generation R Study, a population-based cohort in 
Rotterdam, the Netherlands, designed to identify early determinants of growth, de-
velopment and health.16 In short, children were born between April 2002 and January 
2006 from mothers who were enrolled in early pregnancy. For this study, we selected 
all mother-child dyads with available data on breastfeeding duration (N = 6,205). Valid 
information on child IQ was available in 3,761 (61%) children (Supplementary figure 1). 
Some mothers in our study participated with two (n = 470) or three (n = 12) children. 
Underestimation of standard errors could have resulted due to the clustered nature of 
data among siblings. However, since the number of surplus participants was small (2 
siblings=235; 3 siblings=8) and the associations did not materially change after random 
exclusion of these siblings, they were included in the analysis. The study was con-
ducted in accordance with the guidelines as proposed in the World Medical Association 
Declaration of Helsinki and was approved by the local Medical Ethics Committee. Written 
informed consent was obtained from all adult participants.
Breastfeeding
Information about initiation of breastfeeding was collected from delivery reports; data 
on continuation of breastfeeding was obtained from postal maternal self-report ques-
tionnaires at 2, 6 and 12 months postpartum.40 Breastfeeding duration was defined as 
the age of the child (in months) at which breastfeeding was stopped completely. We used 
duration of any breastfeeding as a continuous variable. Also, we categorized breastfeed-
ing duration as previously described in the literature into <2 months, 2-6 months, 6-10 
months, and >10 months.41 An approximation of exclusiveness of breastfeeding (i.e. the 
infant received no other milk or solids) was defined using information about the age at 
which other types of milk and/or solids were introduced. The information about dura-
tion and exclusiveness of breastfeeding was combined and grouped into the following 4 
breastfeeding categories: (1) never; (2) partial for less than 4 months, not thereafter; (3) 
exclusive for 4 months, and partial thereafter. Since only 37 mothers in our cohort were 
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breastfeeding exclusively at 6 months we included them in group 3 (exclusive breastfeed-
ing at 4 months). In order to differentiate between the determinants of breastfeeding 
initiation and duration, we also compared breastfeeding initiation to never breastfeeding 
and early weaning (<3months)42 to extended breastfeeding (>3months). At age 6 months, 
most children were fed by LCPUFA-fortified brand milk products (in those children for 
which we had accurate brand name data, 61% were fed by fortified brands).
nonverbal Intelligence
At age 6 years (mean age = 6.0 ± 0.4 years), children were invited at the Generation R 
research center. Non-verbal IQ was assessed using two subtests of a Dutch non-verbal 
IQ test: Snijders-Oomen Non-verbal Intelligence Test–Revised (SON-R 2½-7).43 The two 
subsets we used were ‘Mosaics’, which taps into spatial visualization abilities, and 
‘Categories’, which assesses abstract reasoning abilities (Mosaics: 15 items, Cronbach’s 
α = 0.90; Categories: 15 items, Cronbach’s α = 0.95). The raw test scores were converted 
into non-verbal IQ using norms tailored to exact age and sex.43 The correlation of the 
IQ score derived by the mosaics and categories subsets and the IQ scores derived by 
the total test was high (r = 0.86).44 Mean IQ was 102.6 (SD 14.7, range 50–150), which 
corresponds to the general population.43 The study focused only on non-verbal IQ, due 
to the high heterogeneity on ethnic origin in the Generation R study sample. Verbal 
IQ-measures in children with different exposure to the Dutch language would have led 
to high variability in findings, which cannot be attributed to the main determinant in 
focus, but to their ethnic background.
Confounding variables
Confounders were selected on the basis of earlier studies on breastfeeding and child IQ.45 
We included information obtained from midwives and hospital registries on child gen-
der, birth weight (in grams), gestational age at birth, and mode of delivery. Time spent 
in day care (< 8 or ≥8 hours/day) was obtained by questionnaires at infant’s age of 6 and 
12 months. Parity, maternal age, maternal BMI, parental ethnicity, maternal smoking dur-
ing pregnancy, maternal alcohol intake during pregnancy, marital status, family income 
and parental education were assessed by various questionnaires during pregnancy and 
when children were aged 6 years. We classified children of different national origin on 
the basis of country of birth of the parents and grandparents into ‘Dutch’, ‘Moroccan’, 
‘Turkish’, ‘Antillean’, ‘Surinamese’, ‘Cape-Verdean’, ‘other western’ and ‘other non-western’. 
Both maternal and paternal educational levels were defined by the highest completed 
educational level and were classified into three categories: low, intermediate, and high. 
At 20 weeks of gestation, we used the Brief Symptom Inventory (BSI) to measure mater-
nal psychopathology during pregnancy, from which a Global Severity Index (GSI) was 
derived.46 Maternal employment was dichotomized as ‘paid jobs’ versus ‘no jobs’.
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Maternal intelligence was assessed during the accompanying child’s visit to the re-
search center at the age of 6 years using a computerized Ravens Advanced Progressive 
Matrices Test, set I. This set consists of 12 items and has been shown to be a reliable 
and valid short form of the Raven’s Progressive Matrices to assess nonverbal cognitive 
ability parallel to child non-verbal IQ.47 Family functioning was measured at 30 weeks of 
pregnancy using the Family Assessment Device, a 12-item self-report questionnaire.48
In mothers of Dutch origin, we ran additional analyses with further adjustment for 
maternal diet in early pregnancy, which is highly related to maternal diet in the post-
partum period. Maternal nutritional intake in early pregnancy was assessed by using a 
validated semi-quantitative food frequency questionnaire (FFQ). Two dietary patterns 
“Mediterranean” and “Traditionally Dutch” have been extracted previously based on 
the FFQ consisting of 293 food items.49 Presented scores represent the adherence to a 
particular dietary pattern corrected for total daily caloric intake by the mother.
Statistical analysis
We constructed multivariable linear regression models to assess the associations 
between duration of breastfeeding and child IQ and to examine the effect of confound-
ers. We also added quadratic terms for breastfeeding duration to test for non-linear 
associations. Model 1 included child gender, birth weight, birth order, gestational age 
at birth, age of the child at testing and child’s ethnicity. A series of three models were 
run adding a set of variables sequentially to model 1 after another. Model 2 included 
sociodemographic variables, i.e. time spent in childcare, ethnicity, maternal age, ma-
ternal BMI, household income, maternal employment, family functioning, maternal 
education and paternal education. To determine and demonstrate the specific change 
in effect size when adjusting for maternal intelligence, we added maternal IQ as a single 
variable in Model 3. Finally, maternal lifestyle factors including maternal smoking and 
alcohol intake during pregnancy and maternal psychopathology were added in Model 
4. In additional analyses, we varied the order of covariate entry to evaluate whether the 
determined effect size changed.
We reran analyses comparing breastfeeding initiation to never breastfeeding and 
early weaning (<3months) to extended breastfeeding (>3months).To explore whether 
maternal diet affects the association between breastfeeding and child IQ, we ran ad-
ditional analyses in children of mothers of Dutch national origin. Missing values for the 
confounding variables (0.1 – 32.9% missing data) were imputed by multiple imputation 
using chained equations in which 40 completed data sets were generated and analyzed 
by using the standard combination rules for multiple imputation. All levels of associa-
tions are presented with their 95% confidence intervals (CIs). Statistical analyses were 
conducted by using Stata13 (Stata Corp, College Station, TX).
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Table 1. Study Population Characteristics of 3,761 Children with Data on Breastfeeding Duration and Avail-
able non-verbal IQ Scores in The Generation R Study, Rotterdam, The Netherlands.
Any Breastfeeding
Never
n=369
9.8%
<2 months
n=965
25.7%
2-6 months
n=1242
33.0%
6-10 months
n=626
16.6%
>10 months
n=559
14.9%
Group
difference
Child Characteristics
Gender (% girls) 52 51 51 51 53
Cesarean section (%) 18 16 12 11 10 **
Mean birth weight (g)† 3374 (583) 3384 (565) 3420 (572) 3500 (549) 3493 (517) **
Gestational age at birth 
(weeks)†
39.5 (1.8) 39.8 (1.8) 39.8 (1.9) 40.0 (1.7) 40.1 (1.5) **
Prematurity (% preterm) 7 6 6 5 4
Child daycare
 ≥8 hours/week (%) 86 91 92 88 78 **
Child’s age at testing in years † 6.1 (0.4) 6.1 (0.4) 6.0 (0.3) 6.0 (0.4) 6.0 (0.4) *
Child IQ † 100 (13) 100 (15) 104 (15) 105 (15) 104 (15) **
Child Ethnicity
 Dutch (%) 76 70 66 72 55 **
Maternal characteristics
Maternal age at enrollment † 31 (4.8) 30 (5.0) 31 (4.5) 32 (4.4) 32 (4.7) **
Parity (primipara) (%) 50 64 62 55 53 **
Maternal BMI (kg/m2) † 26 (5.4) 25 (4.8) 24 (3.9) 24 (3.7) 24 (3.9) **
Maternal smoking during 
pregnancy (%) 26 20 12 9 8 **
Maternal alcohol during 
pregnancy (%) 37 38 51 51 39 **
Maternal dietary pattern score
 Mediterranean † -0.4 (1.0) -0.2 (0.9) 0.1 (0.9) 0.2 (0.9) 0.4 (1.1) **
 Traditional Dutch† 0.1 (1.0) -0.1 (1.0) -0.1 (0.9) -0.1 (1.0) -0.3 (1.2) **
Maternal psychopathology
during pregnancy (GSI)‡ 0.1 (0.1, 0.3) 0.2 (0.1, 0.4) 0.1 (0.1, 0.3) 0.1 (0.1, 0.3) 0.2 (0.1, 0.3) *
Maternal IQ† 92 (13) 95 (14) 99 (14) 101 (14) 101 (15) **
Socio-demographic characteristics
Family Income in euro/month
 (% high) 68 65 79 77 64 **
Maternal employment (%) 76 80 83 81 74 **
Maternal educational (% high) 30 40 60 70 63 **
Mean family functioning (FAD 
score)‡
1.4 (1.2, 1.8) 1.5 (1.2, 1.9) 1.4 (1.1, 1.8) 1.3 (1.1, 1.8) 1.4 (1.2, 1.8) **
Abbreviations: BMI-Body Mass Index; FAD-Family Assessment Device; GSI-Global Severity Index.
Note: Values are percentages for categorical variables, †mean (SD) for continuous normally distributed variables and ‡ me-
dian (interquartile range) for continuous, non-normally distributed variables. Differences in maternal and child characteris-
tics for the breastfeeding duration groups were evaluated using χ2 tests for categorical variables, ANOVA for normally dis-
tributed continuous variables, and Kruskal-Wallis test for non-normally distributed continuous variables: *P<0.05, ** P<0.01
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RESUlTS
non-response analyses
Missing data analyses were conducted to examine whether non-response was selec-
tive in our study population. Children with available data on the determinant but no 
IQ testing (n = 2,007) were compared to children included in the analysis (n = 3,761) 
(supplementary figure 1). The group of children with missing IQ-data were more often of 
non-Dutch origin (54% compared to 65%, P < 0.001). Their mothers were less likely to be 
primiparous (54.3% compared to 58.6%, P < 0.05), had lower family income (21.6% com-
pared to 11.9%; P < 0.001), and lower education (11.1% compared to 5.8%, P < 0.001). 
No differences were found on maternal age, gender, mean birth weight and gestational 
age at birth.
Sample characteristics
Characteristics of the study population are presented in Table 1. The mean child age at 
which SON non-verbal tests were performed was 6 years. The mean duration of breast-
feeding was 4.5 months (±3.9 months). Children who were never breastfed (9.8%), and 
their mothers, differed on almost every tested covariate from children who received any 
breastfeeding. Most mothers breastfed their children for 2-6 months (non-exclusively). 
Generally, mothers with the most advantageous psychosocial factors were in the group 
who breastfed their children for 6 - 10 months. Longer duration of breastfeeding, 
i.e. > 10 months, was associated with lower maternal IQ, lower family income and more 
psychopathology during pregnancy. Mothers in this category were less often of Dutch 
national origin and used less day care facilities than the majority of the sample. In total, 
23.5% of all children were breastfed exclusively for 4 months.
non-exclusive breastfeeding and child IQ
Table 2 shows the associations of breastfeeding duration with non-verbal IQ in 6 year old 
children. In the initial model, longer duration of breastfeeding was associated with 0.32 
(95% CI 0.20 - 0.44) points higher IQ per month of breastfeeding. The results obtained 
from the analyses using breastfeeding duration as a categorical measure were in line 
with those obtained from the analyses using breastfeeding as a continuous variable. 
The largest effect of breastfeeding was seen for children breastfed for 6-10 months that 
corresponded to an advantage of 4.79 (95% CI 2.96 - 6.62) IQ points compared to chil-
dren who were never breastfed. Each model conferred a substantial reduction in effect 
sizes. Adjustment for socio-demographic factors including parental education, family 
functioning and maternal employment reduced the advantage substantially, both on 
the categorical and the continuous scale. Further strong attenuation of associations was 
seen after adjustment for maternal IQ for all breastfeeding durations and breastfeeding 
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as a continuous variable. To test the full confounding effect of maternal intelligence, we 
re-ran model 1 with inclusion of maternal IQ. In this model, child IQ was 0.19 (95% CI 
0.08 - 0.32) points higher per month extra duration of breastfeeding. Maternal intel-
ligence reduced the effect by 41%, yet maternal age, maternal BMI, family functioning, 
and parental education were also important confounders (Supplementary Table 1).
Introducing a quadratic term for duration of breastfeeding in months did not signifi-
cantly confirm a non-linear association between of breastfeeding duration and child IQ 
(P=0.46).
When we compared children whose mothers initiated breastfeeding (n = 3,392) to 
children that were never breastfed (n=369), the observed 3.10 (95% CI 1.56 – 4.63) IQ 
point advantage in unadjusted analyses reduced to 0.57 (95% CI -0.95 – 2.10) IQ points 
in model 4. Similarly, when comparing children with extended breastfeeding (n = 2,025) 
to early weaning (n = 1,367), the initially observed advantage of 2.50 (95% CI 1.51 – 3.49) 
IQ-points reduced to 0.77 (95% CI -0.24 – 1.78) IQ-points after full adjustment. Again, 
inclusion of sociodemographic characteristics and maternal IQ attenuated the effects to 
non-significant differences between groups.
Table 2. Associations of Breastfeeding Duration with IQ in Six Years Old Children in The Generation R Study, 
Rotterdam, The Netherlands.†
Child IQ SON (n = 3761)
Breastfeeding
duration
Model 1 Model 2 Model 3 Model 4
N b (95% CI) P b (95% CI) P b (95% CI) P b (95% CI) P
Categorical model
Never 369 Reference Reference Reference Reference
<2 months 965 0.99
(-0.71, 2.70) 0.26
0.47
(-1.21, 2.16) 0.58
-0.01
(-1.69, 1.66) 0.99
-0.11
(-1.79, 1.56) 0.89
2-6 months 1242 3.63
(1.97, 5.28) <0.001
1.92
(0.27, 3.58) 0.02
1.12
(-0.53, 2.77) 0.19
0.86
(-0.80, 2.51) 0.31
6-10 months 626 4.79
(2.96, 6.62) <0.001
2.72
(0.88, 4.57) 0.004
1.82
(-0.02, 3.65) 0.05
1.52
(-0.32, 3.36) 0.10
>10 months 559 3.74
(1.85, 5.62) <0.001
1.94
(0.03, 3.83) 0.04
0.82
(-1.08, 2.72) 0.40
0.58
(-1.32, 2.48) 0.55
Continuous model
Breastfeeding 
duration (months)
3761
0.32
(0.20, 0.44)
<0.001
0.17
(0.05, 0.29)
0.004
0.11
(-0.01, 0.23)
0.08
0.09
(-0.03, 0.21)
0.14
Note: Using multiple linear regression models, values given as regression coefficients and 95% CI and P values
† Models are adjusted for confounders as listed. Each variable is added in the following order:
Model 1: Adjusted for gender, birth weight, birth order, gestational age, child ethnicity, age of child at testing
Model 2: Model 1 + time spent in day care + age of mother at intake, BMI of mother at intake, family income, maternal 
employment, family functioning , maternal education, and paternal education
Model 3: Model 2 + maternal IQ
Model 4: Model 3 + maternal smoking during pregnancy + maternal alcohol during pregnancy + maternal psychopathol-
ogy during pregnancy
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Exclusive breastfeeding and child IQ
Table 3 shows the results of the analysis of children with data on exclusive breastfeeding. 
Children who were exclusively breastfed until 4 months had 4.21 (95% CI 2.47 - 5.95) IQ 
points advantage over children who were never breastfed. Adjusting for socio-demo-
graphic factors reduced this advantage to half; 2.07 (95% CI 0.31 - 3.82) points. Again, we 
observed that the association further attenuated after adjustment for maternal IQ. The 
effect of partial breastfeeding until age 4 months also reduced four-fold after adjustment 
for maternal IQ.
Table 3. Association of Exclusive Breastfeeding Duration with IQ in Six Years Old Children in The Generation 
R Study, Rotterdam, The Netherlands.†
Child IQ SON (n = 3469)
Exclusive 
breastfeeding 
duration
Model 1 Model 2 Model 3 Model 4
n b (95% CI) P b (95% CI) P b (95% CI) P b (95% CI) P
Never 369 Reference Reference Reference Reference
Partial until 4 
months
2247 2.53
(0.96, 4.09)
0.002 1.34
(-0.21, 2.90)
0.09 0.62
(-0.92, 2.17)
0.43 0.43
(-1.12, 1.97)
0.59
Exclusive for at 
least 4 months
853 4.21
(2.47, 5.95)
<0.001 2.07
(0.31, 3.82)
0.02 1.14
(-0.61, 2.89)
0.20 0.94
(-0.81, 2.70)
0.29
P for trend <0.001 0.03 0.19 0.25
Note: Using multiple linear regression models, values given as regression coefficients and 95% CI and P values
† Models are adjusted for confounders as listed. Each variable is added in the following order:
Model 1: Adjusted for gender, birth weight, birth order, gestational age, child ethnicity, age of child at testing
Model 2: Model 1 + time spent in day care + age of mother at intake, BMI of mother at intake, family income, maternal 
employment, family functioning, maternal education and paternal education
Model 3: Model 2 + maternal IQ
Model 4: Model 3 + maternal smoking during pregnancy + maternal alcohol during pregnancy + maternal psychopathol-
ogy during pregnancy
Confounding by maternal diet
We conducted additional analyses in children of mothers who were of Dutch national 
origin. The largest effect size of 6.20 (95% CI 3.98 - 8.41) IQ points was seen in children 
breastfed for 6-10 months which reduced to 2.43 (95% CI 0.18 - 4.69) points after com-
bined adjustment for socio-demographic and maternal IQ. After further adjustment for 
maternal lifestyle and dietary factors, this effect changed to 2.24 (95% CI -0.01 - 4.50) 
points for children breastfed 6 – 10 months compared to children who were never 
breastfed (supplementary table 2). In the continuous models, we observed no evidence 
for an association between breastfeeding duration and child IQ after adjustment for 
socio-demographic confounders in exclusively breastfed children of mothers of Dutch 
national origin (supplementary table 3).
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DISCUSSIOn
Overall, we found no evidence that longer duration of breastfeeding (non-exclusive, ex-
clusive or partial) is associated with higher non-verbal IQ at age 6 years when confound-
ing variables are appropriately taken into account. The most important confounders 
were maternal age, maternal BMI, parental education, family functioning, and maternal 
intelligence.
Our study adds knowledge to the existing body of literature on effects of breastfeed-
ing practices on child cognitive development. In the last decade, many observational 
studies described significant associations between breastfeeding and child IQ,18-26 but 
many other observational studies found full attenuation of the effect when adjusting 
for confounding variables.27-32 Most studies with positive results, however, did not have 
maternal intelligence available19-21,23-26 or chose to exclude maternal IQ because of 
high correlation with maternal education,22 whereas studies that did include maternal 
IQ generally reported no association.27,29,30 The only recent study that did account for 
maternal IQ and reported still significant effects of breastfeeding is the one from Belfort 
et al.18 Our study in a nearly three times larger sample did not confirm these findings. 
The sufficiently large sample size could permit us to identify small and subtle effects 
of breastfeeding on child IQ and the role of confounders on the change of these small 
effect sizes.
Another methodological limitation of earlier studies is the potential recall bias due to 
retrospective assessment of breast feeding. Only a few studies, including ours, prospec-
tively assessed breastfeeding at different time-points during the first year of life.18,20-22,32 
By doing this, we were able to look at breastfeeding from different perspectives (any, 
exclusive, partial, duration, and initiation). Results, however, were very similar, suggest-
ing that breastfeeding initiation and breastfeeding duration share similar determinants 
and that the effect on cognitive outcome is attenuated by a similar set of potential 
confounding factors.
Whereas observational studies are hampered by the possibility of residual confound-
ing, this bias is minimized in the single largest trial on human lactation (PROBIT).33 In this 
study, despite showing an overall advantage in IQ, the cluster-adjusted mean differences 
in non-verbal IQ (block designs and matrices) were not significant, which is in line with 
our results. However, the PROBIT trial studies the beneficial effects of a promotion in-
tervention rather than the beneficial (nutritional) effects of breastfeeding. Furthermore, 
the recruitment ended before formula milk was fortified with essential fatty acids.
In the present study, we also attempted to assess the role of maternal nutrition in the 
form of dietary patterns. The content of nutrients, including LCPUFAs, in breast milk is 
variable and depends on sources in the maternal diet.50 Previous studies have looked at 
fish intake and maternal folate levels as markers of a “healthy diet” reporting beneficial 
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effects on child IQ and overall child cognitive and neurodevelopment.18,51 We observed 
a small attenuation of 0.02 IQ points per month of breastfeeding after adjusting for 
maternal dietary patterns. However, interpretation of these results is limited by 1) the 
availability of maternal dietary patterns in mothers of Dutch origin only, 2) information 
collected in pregnancy and not during lactation and 3) lack of biological measures of 
nutrient contents in breast milk.
We observed that mothers with advantageous socio-demographical and psychosocial 
characteristics tend to breastfeed for longer periods, which is likely because these moth-
ers are more aware of the potential beneficial effects of breastfeeding. Nevertheless, in 
the Netherlands, most mothers quit breastfeeding before their child reaches the age of 
6 months. This is hypothesized to be due to the return to work of young mothers – the 
timing of which influences the duration of breastfeeding practices and which varies in 
Western countries.52 This return to work, in the Netherlands on average 3 months after 
giving birth, is also associated to social class and leads to a reduction in breastfeeding 
frequency and duration.53 In our sample, the group of mothers who continued (partial) 
breastfeeding for >10 months is indeed unique as they were the least likely to send their 
children to day care, were less often employed, had lower family income and were less 
likely to be of Dutch origin.
Limitations of the present study include selective attrition of families with low in-
come and low educational level. This would lead to potential selection bias when the 
association between breastfeeding and child IQ in nonparticipating children differed, 
e.g. with respect to breastfeeding practices, IQ and effects of specific confounding 
variables. Furthermore, since these factors were more homogenous in children included 
in the study, this may have resulted in different effect sizes and different confounding 
effects. The use of self-report of breastfeeding without information on the exact number 
of weeks of duration is a second limitation. This could lead to misclassification of the 
exposure. Third, although our study included available information on a large number of 
confounders, the association of interest may further be influenced by other unmeasured 
factors, such as paternal intelligence. On the other hand, we may have overadjusted our 
associations by controlling for several interrelated socioeconomic and health-promoting 
factors.
In conclusion, the observed relationship between cumulative effect of longer duration 
of breastfeeding and child IQ is the result of confounding. Our results suggest that, in 
addition to socio-demographic factors, maternal IQ is the main confounder accounting 
for most of the associations observed between breastfeeding and child IQ regardless of 
the duration of breastfeeding and whether breastfeeding was conducted exclusively. 
Despite the proven benefits of breastfeeding for other child outcomes, it is unlikely that 
breastfeeding, by itself, directly effects child IQ.
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SUPPlEMEnTARy MATERIAl
Supplementary figure 1. Flow chart of study population.
 
3,761 children with valid IQ data at 6 
years; of which 3,469 had valid data 
on exclusiveness of breastfeeding 
35 excluded as they 
were outside the 
age range for IQ 
testing 
2,007 excluded due 
to missing/ 
incomplete/ invalid 
IQ data 
6,205 children with available 
breastfeeding data  
280 excluded due to 
no consent for 
further participation 
 
122 excluded due to 
withdrawal from 
the study  
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ABSTRACT
Background Several markers of subclinical vascular damage affect cognitive function 
in elderly. Arterial stiffness is one such marker. However, it remains unknown whether 
arterial stiffness affects cognition already in early life.
Methods We examined the relation of carotid-femoral pulse-wave velocity (a measure 
of arterial stiffness), systolic and diastolic blood pressures with cognitive function in 
4634 children from the Generation R Study (mean age 6.2 years, 50.7% female) as well 
as 5230 elderly from the Rotterdam Study (mean age 61.8 years, 57.2% female). All par-
ticipants underwent pulse-wave velocity measurement using ultrasound. In children, 
we assessed non-verbal IQ, while in the elderly, a cognitive test battery was employed 
that yielded the g-factor, a standardized measure of global cognitive functioning. Linear 
regression analysis was used to assess the associations of pulse-wave velocity, systolic 
and diastolic blood pressures with non-verbal IQ in children and g-factor in elderly.
Results In children pulse-wave velocity, systolic and diastolic blood pressures were not 
significantly associated with child IQ after adjustment for child, maternal and sociode-
mographic characteristics. In elderly, each standard deviation increase in pulse-wave 
velocity and systolic blood pressure were significantly associated with 0.04 (95% CI 
-0.072 - -0.008) decrease in g-factor after adjustment for age, gender, education, BMI, 
smoking, diabetes, and blood pressure lowering medication. These associations were 
primarily driven by participants younger than 75 years. Diastolic blood pressure was not 
related to g-factor in the elderly.
Conclusions The association of arterial stiffness with cognitive function is not evident 
in early childhood. Its accumulation throughout the ageing process may be responsible 
for cognitive changes in old age.
45
The association of arterial stiffness with cognition in young and old
2.2
InTRODUCTIOn
Vascular damage plays a role in cognitive decline in old age. Previous studies have 
identified several vascular risk factors that are related to poor cognitive function in 
adults and elderly.1 From the various vascular risk factors, arterial stiffness is of particular 
interest because it has been linked to cognitive impairment independently of traditional 
vascular risk factors.2,3 This could be due to structural and functional changes of the 
vessel walls in the brain that are a result of increased arterial stiffness.3 Arterial stiffness 
is also related to increased blood pressure that adversely affects the brain microcircula-
tion.4,5 A previous study has shown that increased blood pressure is inversely related to 
cognitive function in old age but these associations differed across age groups.6
There is also evidence that vascular damage actually starts accumulating very early in 
life.7 Whether early life vascular influences affect late-life health, particularly cognitive 
health has been understudied. Thus, we aimed to investigate the relation of subclini-
cal vascular risk factors with cognitive function in early life that can give a clue about 
vascular pathology that may be associated with cognitive decline in late life. To this aim, 
we studied the associations of arterial stiffness, systolic and diastolic blood pressures 
with cognition in children and in the elderly.
METHODS
Study population
Generation R Study
The Generation R Study is a population-based cohort in Rotterdam, the Netherlands, 
designed to identify early determinants of growth, development and health.8 In short, 
children were born between April 2002 and January 2006 from mothers who were en-
rolled in early pregnancy. For this study, we selected 4634 children with available data 
on pulse wave velocity, systolic blood pressure, diastolic blood pressure and child IQ 
that were included in the analysis. The study was conducted in accordance with the 
guidelines as proposed in the World Medical Association Declaration of Helsinki and 
was approved by the local Medical Ethics Committee. Written informed consent was 
obtained from all adult guardians of the participants.
Rotterdam Study
The Rotterdam Study is a large prospective population-based cohort that started in 1990 
among inhabitants aged ≥55 years residing in a district of Rotterdam, the Netherlands 
(N=7,983). An expansion of the cohort took place in year 2000, consisting of 3,011 par-
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ticipants who had become 55 years of age or moved into the study district since the 
start of the study. In 2006, a further extension of the cohort was initiated in which 3,932 
subjects were included, aged 45–54 years, out of 6,057 invited, living in the Ommoord 
district.9 The Rotterdam Study has been approved by the medical ethics committee 
according to the Population Study Act Rotterdam Study, executed by the Ministry of 
Health, Welfare and Sports of the Netherlands. A written informed consent was obtained 
from all participants. For the present study, 5235 participants with complete data on 
pulse wave velocity, systolic blood pressure, diastolic blood pressure, and g-factor were 
included in this analysis. Aortic and common carotid artery stiffness were measured 
during the third examination phase of the first cohort (RS I-3); first examination phase 
of the second cohort (RS II-1) and the first examination phase of the third cohort (RS 
III-1);g-factor was measured during the fourth examination phase of the first cohort (RS 
I-4); second examination phase of the second cohort (RS II-2) and the first examination 
phase of the third cohort (RS III-1).9 Blood pressure measurements were taken prior to 
the assessment of carotid-femoral PWV during the same visit. Participants with preva-
lent dementia (n=527) were excluded at the time of arterial stiffness measurement from 
the analyses.
Measurement of blood pressure and carotid femoral pulse-wave velocity
Generation R Study
We measured blood pressure with the child in supine position quietly awake. Systolic 
blood pressure (SBP) and diastolic blood pressure (DBP) were measured at the right 
brachial artery, 4 times with 1-minute intervals, using the validated automatic sphyg-
manometer Datascope Accutor Plus (Paramus, NJ).10 A cuff was selected with a cuff width 
approximately 40% of the arm circumference and long enough to cover 90% of the arm 
circumference. More than 90% of the children who visited the research center had 4 
successful blood pressure measurements available. SBP and DBP were determined by 
excluding the first measurement and averaging the other measurements. Carotid–femo-
ral pulse wave velocity, the reference method to assess aortic stiffness,11 was assessed 
using the automatic Complior device (Artech Medical, Pantin, France) with participants 
in supine position. The distance between the recording sites at the carotid (proximal) 
and femoral (distal) artery was measured over the surface of the body to the nearest 
centimeter. Through piezoelectric sensors placed on the skin, the device collected 
signals to assess the time delay between the pressure upstrokes in the carotid artery 
and the femoral artery. Carotid–femoral pulse wave velocity was calculated as the ratio 
of the distance travelled by the pulse wave and the time delay between the feet of the 
carotid and femoral pressure waveforms, as expressed in meters per second.12 To cover a 
complete respiratory cycle, the mean of at least 10 consecutive pressure waveforms was 
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used in the analyses. Recently, it has been shown that pulse wave velocity can be mea-
sured reliably with good reproducibility in a large pediatric population-based cohort.13
Rotterdam Study
Aortic and common carotid artery stiffness were measured with participants in supine 
position. Before measurement of PWV, blood pressure was measured twice with a sphyg-
momanometer after 5 minutes of rest, and the mean was taken as the subject’s reading. 
Carotid-femoral PWV was assessed with an automatic device (Complior, Colson)12 that 
assessed the time delay between the rapid upstroke of the feet of simultaneously re-
corded pulse waves in the carotid artery and the femoral artery. The distance traveled 
by the pulse wave between the carotid artery and the femoral artery was measured over 
the surface of the body with a tape measure. PWV was calculated as the ratio between 
the distance traveled by the pulse wave and the foot-to-foot time delay and expressed 
in meters per second. The average of at least 10 successive measurements, to cover a 
complete respiratory cycle, was used in the analyses.
Intelligence
Nonverbal IQ in children
At age 6 years (mean age = 6.0 ± 0.4 years), children were invited at the Generation R 
research center. Non-verbal IQ was assessed using two subtests of a Dutch non-verbal 
IQ test: Snijders-Oomen Non-verbal Intelligence Test–Revised (SON-R 2½-7).14 The two 
subsets we used were ‘Mosaics’, which taps into spatial visualization abilities, and 
‘Categories’, which assesses abstract reasoning abilities (Mosaics: 15 items, Cronbach’s 
α = 0.90; Categories: 15 items, Cronbach’s α = 0.95). The raw test scores were converted 
into non-verbal IQ using norms tailored to exact age and sex.14 The correlation of the 
IQ score derived by the mosaics and categories subsets and the IQ scores derived by 
the total test was high (r = 0.86).15 Mean IQ was 101.0 (SD 15.0, range 50–150), which 
corresponds to the general population.14 The study focused only on non-verbal IQ, due 
to the high heterogeneity on ethnic origin in the Generation R study sample. Verbal 
IQ-measures in children with different exposure to the Dutch language would have led 
to high variability in findings, which cannot be attributed to the main determinant in 
focus, but to their ethnic background.
g-factor in elderly16
Cognition can be studied by utilizing tests that determine cognitive functioning in a 
variety of cognitive domains. However, it is equally important to study global cognition 
that consists of a general underlying construct which is not dependent on any specific 
domain and reflects an individual’s general cognitive function. This construct is linked to 
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intelligence and can be quantified as a general cognitive factor, or g-factor.16 To calcu-
late a g-factor, we performed a principal component analysis incorporating color-word 
interference subtask of the Stroop test, LDST, verbal fluency test, delayed recall score of 
the 15-WLT, and Purdue pegboard test. For tests with multiple subtasks we chose only 
one subtask in order to prevent highly correlated tasks distorting the factor loadings. 
Principal component analysis was performed on complete case data of 5,235 persons. 
The g-factor was identified as the first unrotated component of the principal compo-
nent analysis and explained 49.2% of all variance in the cognitive tests. This is a typical 
amount of variance accounted for by the g-factor. The g-factor is thus a stable concept, 
comprising the shared variance between cognitive tests, and can be interpreted as a 
common underlying factor to a variety of cognitive domains.
Measurement of Covariates
Generation R Study
We included information obtained from midwives and hospital registries on child 
gender, birth weight (in grams) and complications during delivery. Weight of the child 
was measured while the child was wearing lightweight clothes and without shoes by 
using a mechanical personal scale (SECA, Birmingham, United Kingdom), and height 
was measured by a Harpenden stadiometer (Holtain Limited, Dyfed, United Kingdom) 
in standing position; both the scale and stadiometer were calibrated on a regular basis. 
BMI was calculated using the formula; weight (Kg)/height (m)2 . Maternal age, maternal 
smoking during pregnancy and maternal education were assessed by various question-
naires during pregnancy. Maternal height was measured during visits at our research 
center. On the basis of height and pre-pregnancy weight, we calculated pre-pregnancy 
BMI (weight (Kg)/height (m)2). Maternal educational level was defined by the highest 
completed educational level and was classified into three categories: low, intermedi-
ate, and high. Mean arterial pressure (MAP) was calculated by the following formula: 
diastolic blood pressure+1/3×(systolic blood pressure − diastolic blood pressure).
Rotterdam Study
We used covariates measured at baseline of each examination round. Smoking status 
and information on the number of cigarettes smoked per day in each decade of life 
was obtained by a self-administered questionnaire during the home interview. Smoking 
status was characterized as never, past and current smoking. Participants were also 
invited to visit the research centre for clinical examinations and laboratory assessments. 
Body mass index (BMI) was measured using weight in kilograms divided by the square 
of height in meters. Diabetes mellitus type-2 was defined as having a fasting glucose 
level of ≥7.0 mmol/L or using blood glucose–lowering medication. Data on indication 
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for use of blood pressure-lowering medication were based on information collected 
by a physician at the research centre. Mean arterial pressure (MAP) was calculated by 
the following formula: diastolic blood pressure+1/3×(systolic blood pressure—diastolic 
blood pressure).
Statistical analysis
We constructed multivariable linear regression models to assess the associations 
between arterial stiffness and IQ in children and g-factor in elderly. In children, Model 
1 included child age, gender, birth weight, and BMI. Model 2 included the following 
maternal characteristics: education, BMI, smoking during pregnancy, diabetes and 
use of blood pressure lowering medication. For the models with arterial stiffness as a 
determinant, additional adjustments were made for mean arterial pressure, heart rate 
and ultrasound device in Model 2.
In the elderly population within the Rotterdam Study, all models were adjusted for 
age, gender and cohort. Since the exposure and outcome were measured on two sepa-
rate examination rounds in the first (PWV in RS I-3 and RS II-1) and second (g-factor in 
RS I-4 and RS II-2) cohorts, we additionally adjusted for the time interval time between 
exposure and outcome measurements in Model 1. We subsequently adjusted for educa-
tional level, BMI, Smoking status, diabetes mellitus type-2, and, blood pressure lowering 
medication in Model 2. For the models with arterial stiffness as a determinant, additional 
adjustments were made for mean arterial pressure, and heart rate in Model 2.
To investigate whether very old age affected the association between arterial stiffness 
and blood pressure with g-factor, we performed a subgroup analysis in strata of age 
(cut-off of 75 years).
Missing values for the confounding variables (0.1–16.2% missing data in Generation R 
Study and 0.6–1.9% missing data in the Rotterdam Study) were imputed by multiple im-
putation using chained equations in which 40 completed data sets were generated and 
analyzed by using the standard combination rules for multiple imputation. All levels of 
associations are presented with their 95% confidence intervals (CIs). Statistical analyses 
were conducted by using Stata13 (Stata Corp, College Station, TX).
Results
Generation R study
Characteristics of the study populations are presented in Table 1. The mean child age 
at which SON non-verbal tests were performed was 6.2 (0.5) years. The mean carotid-
femoral pulse wave velocity was 5.5 (0.9) m/s, the mean systolic blood pressure was 
102.7 (8.3) mm Hg and the mean diastolic pressure was 60.8 (6.8) mmHg. He average 
child IQ was 101.0 (15.0) points. More than half of the children’s mothers were Dutch in 
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origin. The average maternal age at the time of delivery was 30.6 (5.1) years. 47% of the 
maternal population was highly educated and their average IQ was 95.7 (15.3) points.
Table 1: Baseline characteristics of the Generation R study population
Study population characteristics Participants
generation R Study n=4634
Child characteristics
Gestational age at birth, weeks 39.8 (1.9)
Birth weight, g 3399.6 (573.3)
Gender, n (% female) 2348 (50.7%)
Age at outcome, years 6.2 (0.5)
BMI, kg/m2 16.2 (1.8)
IQ child 101.0 (15.0)
Systolic blood pressure, mmHg 102.7 (8.3)
Diastolic blood pressure, mmHg 60.8 (6.8)
Carotid-femoral pulse wave velocity, m/s 5.5 (0.9)
Heart rate, beats/min 82.2 (11.9)
Mean arterial pressure, mmHg 88.7 (7.1)
Maternal characteristics
Ethnicity, n (%)Dutch 2459 (54.4)
Maternal age, years 30.6 (5.1)
Maternal BMI, kg/m2 24.8 (4.4)
Maternal smoking during pregnancy, n (%) 650 (16.3%)
Maternal education
 Low, n (%) 384 (9.1%)
 Intermediate, n (%) 1849 (43.9%)
 High, n (%) 1981 (47.0%)
Preeclampsia, n (%) 83 (2.1%)
Maternal IQ 95.7 (15.3)
Values are means (standard deviation) or number of participants (percentage).
Table 2 shows the associations of carotid-femoral PWV, systolic and diastolic blood pres-
sures with non-verbal IQ in 6 year old children. In the initial model, adjusted for child 
characteristics that included child age, gender, birth weight, and BMI, each standard 
deviation increased in diastolic blood pressure was associated with -0.43 (95% CI -0.85 
- -0.02) point decrease child IQ. A strong attenuation of effect sizes to non-significant 
results were observed for all determinants after adjusting for maternal characteristics in 
the fully-adjusted model. Ethnicity, maternal BMI, maternal education and continuation 
of smoking during pregnancy were important covariates.
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Table 2: Association between z-scores of blood pressure, pulse wave velocity and child IQ at age 6 years 
(Age range 4.8 – 9.1 years)
N β (95% CI) P value β (95% CI) P value
Model 1 Model 2
Carotid-femoral pulse wave 
velocity†
4634 -0.182 (-0.600, 0.236) 0.393 -0.167 (-0.578, 0.245) 0.427
Systolic blood pressure 4634 -0.371 (-0.799, 0.057) 0.089 -0.225 (-0.647, 0.197) 0.296
Diastolic blood pressure 4634 -0.434 (-0.850, -0.018) 0.041 -0.295 (-0.706, 0.116) 0.159
N, number of persons in the total population; CI, confidence interval
Model 1: Adjusted for child characteristics: child age at outcome, gender, birth weight, and child BMI at outcome
Model 2: Model 1 + maternal characteristics: ethnicity, maternal BMI, maternal smoking, maternal education, and pre-
eclampsia
†Additionally adjusted for heart rate and mean arterial pressure and ultrasound device
Rotterdam Study
Characteristics of the study population are presented in Table 3. The mean age was 61.8 
(7.0) years, with 18.5% who had attained a high level of education. The mean carotid-
Table 3: Baseline characteristics of the Rotterdam Study population
Study population characteristics Participants
Rotterdam Study (RS-I-3, II-1& III-1) n=5230
Elderly characteristics
Age, years 61.8 (7.0)
Gender, n (% female) 2991 (57.2%)
BMI, kg/m2 27.1 (4.0)
Smoking
Never, n (%) 1611 (31.1%)
Current, n (%) 1013 (19.5%)
Past, n (%) 2560 (49.4%)
Education
Low, n (%) 499 (9.7%)
Intermediate, n (%) 3702 (71.8%)
High, n (%) 955 (18.5%)
Diabetes, n (%) 503 (9.7%)
Systolic blood pressure, mmHg 143.7 (21.5)
Diastolic blood pressure, mmHg 83.5 (10.4)
Blood pressure lowering medication, n (% yes) 1544 (30.1%)
Carotid-femoral pulse wave velocity, m/s 11.6 (3.0)
Heart rate, beats/min 71.5 (12.9)
Mean arterial pressure, mmHg 103.5 (13.0)
Values are means (standard deviation) or number of participants (percentage).
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femoral pulse wave velocity was 11.6 (3.0) m/s, the mean systolic blood pressure was 
143.7 (21.5) mm Hg and the mean diastolic pressure was 83.5 (10.4) mmHg.
Table 4 shows the associations of z-scores of carotid-femoral PWV, systolic and 
diastolic blood pressures with g-factor in the elderly population. In the initial model, 
adjusted for age, gender, cohort and time difference between exposure and outcome 
measurements, one standard deviation increase in carotid–femoral PWV was associated 
with -0.07 (95% CI -0.10 - -0.04) point decrease in g-factor and one standard deviation 
increase in systolic blood pressure was associated with -0.06 (95% CI -0.09 - 0.04) point 
decrease in g-factor. Diastolic blood pressure was not significantly associated with g-
factor. The association between PWV and systolic blood pressure with g-factor did not 
change significantly after adjustment for educational status, BMI, smoking status, preva-
lent diabetes and blood pressure lowering medication (β -0.04 (95% CI -0.07 - -0.01) and 
β -0.04 (95% CI -0.06 - -0.02) respectively) in the fully-adjusted model.
After we stratified our study sample by age (cut-off 75 years), we observed significant 
associations between PWV (β 0.04 (95% CI -0.08 - -0.01)) and systolic blood pressure (β 
0.04 (95% CI -0.07 - -0.02)) with g-factor in participants aged less than 75 years in the 
fully-adjusted model. No significant associations were observed in persons >75 years.
Table 4: Association between z-scores of blood pressure, pulse wave velocity and g-factor in the Rotterdam 
study (I-3, II-1& III-1) (Age range: 45.7-93.9)
N β (95% CI) P value β (95% CI) P value
Model 1 Model 2
Carotid-femoral pulse wave 
velocity†
5230 -0.068 (-0.098, -0.038) <0.001 -0.040 (-0.072, -0.008) 0.013
<75 years 4955 -0.074 (-0.106, -0.043) <0.001 -0.044 (-0.077, -0.010) 0.011
≥75 years 275 -0.006 (-0.107, 0.096) 0.912 -0.002 (-0.109, 0.105) 0.972
Systolic blood pressure 5230 -0.061 (-0.086, -0.037) <0.001 -0.039 (-0.064, -0.015) 0.002
<75 years 4955 -0.063 (-0.088, -0.038) <0.001 -0.042 (-0.067, -0.017) 0.001
≥75 years 275 -0.033 (-0.147, 0.081) 0.568 0.001 (-0.113, 0.115) 0.987
Diastolic blood pressure 5230 -0.022 (-0.045, -0.001) 0.059 -0.007 (-0.030, 0.016) 0.557
<75 years 4955 -0.025 (-0.048, -0.001) 0.041 -0.009 (-0.033, 0.014) 0.437
≥75 years 275 0.005 (-1.104, 0.095) 0.926 0.016 (-0.083, 0.116) 0.744
N, number of persons in the total population; CI, confidence interval
Model 1: Adjusted for age, gender, cohort and time difference between exposure and outcome measurements
Model 2: Model 1 + education, BMI, smoking, diabetes, and blood pressure lowering medication
†additionally adjusted for heart rate and mean arterial pressure in Model 2
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DISCUSSIOn
In this large prospective cohort study comprising of two populations at both extremes 
of the life-span, we found that arterial stiffness, systolic and diastolic blood pressures 
are not related to non-verbal IQ in children of age 6 years. While in the elderly, we found 
that increase in arterial stiffness and systolic blood pressure was associated with decline 
in g-factor. Persons aged less than 75 years primarily governed these findings. Diastolic 
blood pressure was not associated with g-factor in the elderly.
Arterial stiffness is considered one of the earliest detectable marker of structural 
and functional changes in the vessel wall that may precede cardiovascular injury.17 
Previous studies have shown that arterial stiffness is not only an independent marker of 
cardiovascular disease but also a strong predictor of cognitive impairment.18-20 Previous 
studies have also found significant inverse associations between arterial stiffness and 
cognitive function in the elderly.18,21,22 The possible mechanism in the explanation of the 
association between arterial stiffness and cognitive impairment is direct insult to distal 
vasculature in the brain due to decreased wave-reflection between aorta and carotids 
and increased transmission of excessive pulsatility into the brain.23 There is also evidence 
that increased arterial stiffness also affects the integrity of the brain microvasculature 
that may cause insufficiency in cerebral perfusion, accumulation of which combined 
with reduced flow to the brain parenchyma may result in microvascular ischemia that 
may lead to cognitive impairment.24 In the present study, the association between 
arterial stiffness and g-factor differs across age groups with a cut-off of 75 years, above 
which there is no association between arterial stiffness and g-factor. One explanation 
of these findings could be that stiffening of arteries reaches a maximum in very old 
age in order to maintain adequate cerebral perfusion to sustain life. As a result, the lack 
of further decline in perfusion may just be enough to preserve cognitive function at a 
standstill without any further deterioration.
We also observed that systolic blood pressure was associated with decline in g-factor 
in the elderly. This could be because arterial stiffness may result in lower vascular disten-
sibility that may be a predecessor of systolic hypertension.25 Another explanation is that 
the relation between arterial stiffness and blood pressure that affects cognition may 
be bidirectional; Long term elevated blood pressure that start in young adults can lead 
to vascular remodeling with structural changes in the vessel walls that result in their 
stiffening.25 One study also showed that the relationship between blood pressure and 
cognitive function is highly dependent on age.6 In this study hypertensive persons <75 
years old showed cognitive decline later in life. On the contrary, persons >75 years who 
had elevated blood pressure had better cognitive outcomes. Therefore, slightly elevated 
blood pressure, maintained in the pre-hypertensive range has been shown to be ben-
eficial for cognition in persons older than 75 years.26 Although in our study, the effect 
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size of the association between systolic blood pressure and g-factor among ≥75 year old 
persons is very small and not significant in the fully-adjusted model; the inverse nature 
of it may indicate that higher systolic blood pressure is required to maintain perfusion 
pressure in very old persons in order to preserve cognitive function.
A major strength of our study is the large sample size in a population-based setting 
of both child and adult populations. In this study we combined several executive func-
tion tests that accounts for a global measure of cognition in various cognitive domains 
instead of using cognitive tests separately.3 A limitation of our study is that very old 
persons with advanced cognitive impairment were not capable of participation in the 
study. Therefore, selective attrition may have influenced our results. In children, we 
measured non-verbal IQ owing to the high diversity in ethnic background. However, in 
elderly, the g-factor included verbal fluency test. Another limitation is that there is no 
data available on participants of age ranging from 6 years to 45 years. Future studies 
should explore the relation between arterial stiffness, blood pressure and cognitive 
function through the life course by including participants of all ages.
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ABSTRACT
Background Subjective indicators of various aspects of well-being have been related 
to mortality, but their independent relation remains unknown. We aimed to determine 
which aspect of subjective well-being is associated with mortality. To this aim, we tested 
the independent relation of various subjective well-being measures with all-cause 
mortality.
Methods We studied the relation of subjective well-being with all-cause mortality. 
Subjective well-being was measured by various instruments that included basic activities 
of daily living (BADL), instrumental activities of daily living (IADL), quality of life (QoL), 
somatic symptoms, positive affect, and negative affect. Participants were evaluated for 
each measure of subjective well-being and followed for mortality for a mean of 12.2 
years (SE=0.09). Cox regression analysis was conducted in the total sample.
Results In this cohort, 2021 persons died during 48,534 person-years of follow-up. All 
measures of subjective well-being were initially related to mortality after adjusting for 
age, gender, education, cognition, prevalent chronic diseases, and cardiovascular risk 
factors (BADL hazard ratio (HR)=1.35; 95% confidence interval (CI) 1.29-1.41)); (IADL 
(HR=1.27; 95% CI 1.22 - 1.32)); (QoL HR=0.84; 95% CI 0.81 - 0.88)); somatic symptoms 
(HR=1.11; 95% CI 1.06 - 1.16)); negative affect (HR=1.05; 95% CI 1.01 - 1.10)); positive 
affect (HR=0.92; 95% CI 0.88 - 0.96)). In the mutually adjusted model, only basic activities 
of daily living (HR=1.24; 95% CI 1.16 - 1.32) and instrumental activities of daily living 
(HR=1.10; 95% CI 1.04 - 1.17) remained independently associated with mortality.
Conclusions Measures of subjectively assessed well-being are important indicators of 
mortality. The best independent subjective well-being measure predicting mortality in 
older individuals is self-rated physical functioning.
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InTRODUCTIOn
Subjective well-being is defined as a summary measure of how people perceive their 
functioning across multiple domains.1 Previous research on the assessment of subjective 
well-being was mostly conducted within the realm of psychological research focused 
on life satisfaction and mental aspects of well-being such as positive affect and lack of 
negative affect. Perception of physical functioning is, however, understudied. Against 
this background, we conceptualised subjective well-being as a continuum consisting of 
physical functioning at one end and mental health at the other (Figure 1 and Table 1). 
Within the possible parameters of this continuum, we emphasized the various measures 
of subjective well-being in the present study. Each subjective well-being measure serves 
as a specific combination of items or indicators, which cover a broad aspect of physical 
functioning and mental health. A large aspect of overall subjective physical functioning 
is assessed by basic activities of daily living (BADL) that directly measure locomotive 
health in daily functioning such as eating, bathing, and grooming; and instrumental 
activities of daily living (IADL), which cover the cognitive attributes of performing 
self-reliant daily tasks such as meal preparation, shopping, and managing finances.2 
Similarly, the broad aspect of mental health is evaluated by somatic symptoms (i.e. the 
physical manifestations of depression), negative affect (i.e. symptoms of depressive 
mood) and positive affect (i.e. the level of happiness). Finally, we studied quality of life 
that assesses perceived general well-being of daily life and aims to bridge the physical 
and mental attributes of overall well-being (Figure 1 and Table 1). Importantly, any of 
these indicators is affected strongly by both physical and mental aspects of health, even 
if the instruments directly measure only one of these specific aspects.
Previous literature suggests that lower ratings on subjective well-being questionnaires 
are strongly associated with mortality in population studies.3-5 Therefore, measures of 
subjective well-being can be used for screening of health, health outcomes and mortal-
ity on a population level. It is also suggested that each measure of subjective well-being 
shows some degree of independence.6 Therefore, in order to distinguish the associations 
Table 1. Guidance for conceptual terminology used throughout the text.
Concept/aspect Measure/indicator Scale
Physical functioning BADL Stanford health assessment questionnaire
IADL IADL scale by Lawton and Brody
Quality of life Quality of life (QoL) FLZ
Mental health Somatic symptoms* Somatic scale of CES-D
Negative affect Negative effect scale of CES-D
Positive affect Positive affect scale of CES-D
*Somatic symptoms of depression
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between specific aspects of subjective well-being and mortality, it becomes important 
to determine the independent effect of different measures of subjective well-being on 
mortality that largely remains unclear in previous literature.
Our study aims to investigate the associations of six different measures of subjective 
well-being with all-cause mortality. Furthermore, we aimed to determine the indepen-
dent associations of these subjective well-being measures with all-cause mortality if 
mutually adjusted.
METHODS
Study Population
This study was embedded in the Rotterdam Study, a prospective population-based 
cohort that started in 1990 among inhabitants aged ≥55 years residing in a suburb of 
Rotterdam, the Netherlands.7 The Rotterdam Study has been approved by the medical 
ethics committee according to the Population Study Act Rotterdam Study, executed by 
the Ministry of Health, Welfare and Sports of the Netherlands. Written informed consent 
was obtained from all participants. For the present study, the completed measurements 
figure 1. A conceptual framework of overall subjective well-being.*
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in 6055 persons taken between 2002 and 2005 constituted the baseline. After exclusion 
of participants with missing interview dates (n=5), with baseline missing data on one of 
the determinants (IADL (n=169); BADL (n=58); QoL (n=114); negative affect (n=9); posi-
tive affect (n=12)), and prevalent dementia (n=150), information on each determinant 
was available from 5538 participants for analyses. The total number of person-years in 
the analysis of total all-cause mortality was 48,534 person-years (mean follow-up 12.2 
years (SE=0.09).
Measures and Scales
Assessment of Basic Activities of Daily Living (BADL)
BADL was measured using the Dutch version of the disability index from the Stanford 
Health Assessment Questionnaire.8 The disability index consists of 20 items constituting 
eight components: dressing and grooming, arising, eating, walking, hygiene, grip, reach, 
and activities. Two of the three items belonging to the eating component (ability to 
cut meat and ability to life a glass) were combined into one item. Each item was scored 
from 0 to 3, with higher scores indicating worse ability: 0 = without any difficulty, 1 = 
with some difficulty, 2 = with much difficulty, 3 = unable to. The component score was 
calculated as the value of the highest scored item available within that component. The 
overall BADL score was calculated by summing all component scores, thus obtaining a 
score between 0 and 24.8
Assessment of Instrumental Activities of Daily Living (IADL)
IADL was measured using the IADL scale by Lawton and Brody.9 The IADL scale consists 
of eight complex tasks that require higher cognitive abilities to successfully live inde-
pendently: telephone use, medication maintenance, shopping, traveling on your own, 
management of finances, laundry, housekeeping, and meal preparation. Consistent with 
the disability index, we scored items from the IADL scale from 0 to 3. For telephone use, 
participants using an adapted phone were categorized as 2 (with much difficulty). The 
IADL score was subsequently calculated by summing the scores on all individual items, 
obtaining a score between 0 and 24.
Assessment of Quality of Life (QoL)
A short questionnaire for measuring QoL adapted from Questions on Life Satisfaction 
measure (in the original German: Fragen zur Lebenszufriedenheit- FLZM) was used.10 
This module contains eight dimensions of health (including physical condition/fitness, 
ability to relax, energy/vitality, mobility, vision and hearing, freedom from anxiety, free-
dom from aches and pains, and independence from help/care) which the subject must 
rate twice on a four-point scale; once for the subjective importance of the component 
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and once for the subjective degree of satisfaction with this area. The importance and 
satisfaction ratings are then combined to yield the weighted satisfaction score, which 
varies from -12 and +20 for each dimension.10 The sum of eight individual weighted 
satisfaction scores represents overall quality of life.
Somatic Symptoms, Negative Affect and Positive Affect
We present data for somatic symptoms, negative affect and positive affect that indi-
cate mental health. These measures are included in the Center for Epidemiological 
Studies Depression Scale (CES-D). The CES-D is a validated, widely used standardized 
self-report instrument that broadly assesses current depressive symptoms.11 The CES-D 
scale consists of 20 items, reported on a four-point scale indicating mood and feelings 
experienced in the past week: 0 = “Rarely or none of the time (0-1 day)”, 1 = “Some or 
a little of the time (1-2 days)”, 2 = “Occasionally or a moderate amount of the time (3-4 
days)”, and 3 = “Most or all of time (5-7 days)”. The CES-D has four underlying factors: 
interpersonal relations, somatic symptoms, negative affect and positive affect.11 12 We 
selected the somatic scale, which emphasizes the experience of physical symptoms 
related to depression. Seven scale items relate to somatic symptoms that are summed to 
produce a score range from 0 to 21. Also, we tested the negative affect scale with seven 
items related to depressed affect. These are summed to produce a score range from 0 
to 21. Further, we tested positive affect. Four scale items relate to positive affect, which 
are reversed coded and summed producing a score range from 0 to 12. Weighted scores 
were calculated if 25% or less of questions were missing.
Assessment of Mortality
Municipal records were checked bimonthly for information on vital status. In addition, 
deaths were continuously reported through automatic linkage of general practitioner 
files. Research physicians reviewed all available information and coded the events ac-
cording to the International Classification of Diseases, 10th edition (ICD-10). The follow-
up was complete until October 1, 2015.
Other measures
Smoking habits were assessed during home interview asking participants whether they 
were currently smoking cigarettes, cigars, or pipe. Information on alcohol consumption 
was also assessed using home interview. The attained level of education was measured 
and educational levels were defined by highest completed educational level and classi-
fied into three categories: low, intermediate, and high. Participants were invited to visit 
the research centre for clinical examinations and laboratory measurements. Body mass 
index was determined using weight divided by the square of height. Total cholesterol 
and HDL-cholesterol levels were acquired by an automated enzymatic procedure. Blood 
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pressure was measured at the research center twice in the sitting position on the right 
arm with a random zero sphygmomanometer. The average of the 2 measurements 
was used in the analyses. Diabetes mellitus was defined as a fasting glucose level of 
≥7.0 mmol/L or use of blood glucose–lowering medication. Prevalent heart failure at 
baseline was measured using a validated score, that was based on the heart failure 
definition of the European Society of Cardiology.13 Joint problems were obtained from 
home interview and a physician also measured the participants for joint complaints. 
Radiographic assessment for the diagnosis of osteoarthritis and rheumatoid arthritis 
were made at the research centre. Cognitive function was tested by trained investiga-
tors with the 30-point Mini-Mental State Examination (MMSE). A history of stroke was 
determined by interview or proxy informant interview. Confirmation of stroke diagnosis 
by a treating physician was required. A previous myocardial infarction was determined 
using an electrocardiogram. Diagnosis of COPD was confirmed by spirometry.
STATISTICAl AnAlySIS
We first examined the Spearman rank-order correlations between BADL, IADL, QoL, 
somatic symptoms, negative affect and positive affect. Next, we investigated the as-
sociations of each measure of subjective well-being with all-cause mortality using 
Cox proportional hazards models adjusting for confounders. The proportional hazard 
assumption was evaluated using Schoenfeld residuals.14 The underlying time-scale in 
these models was the follow-up time in years, which was complete until October 1, 
2015. Participants were censored within this follow-up period at date of death, date of 
loss to follow-up, or October 1, 2015, whichever date came first.
We presented the results per Z-score for a uniform representation of data. All models 
were adjusted for age and sex. Next, we adjusted for education level, MMSE, joint prob-
lems, prevalent stroke, prevalent myocardial infarction (MI), prevalent diabetes mellitus, 
prevalent chronic obstructive pulmonary disease (COPD), prevalent heart failure, BMI, 
smoking, and alcohol consumption. In order to test the independent association of 
each subjective well-being measure with mortality, we further mutually adjusted for the 
other measures in a third model.
To investigate whether the association between subjective well-being and mortality 
remained after the exclusion of participants with a psychiatric diagnosis, we excluded 
participants with major depressive disorder (n=109) at baseline in a sensitivity analysis. 
A trained psychiatrist, geriatrician or psychologist conducted a semi-structured psy-
chiatric interview in persons with depressive symptoms as defined by a CES-D score 
of 16 or above, which is considered indicative of a depressive disorder.15 This interview 
was performed with the Schedules for Clinical Assessment in Neuropsychiatry (SCAN).16 
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Major depressive disorder (MDD) was classified according to the DSM-IV criteria, with an 
algorithm based on the item-scores.15
Missing values for the confounding variables (0.1 – 13.2% missing data) were imputed 
by multiple imputation using chained equations in which 40 completed data sets were 
generated and analysed by using the standard combination rules for multiple imputa-
tion. All analyses were done using Stata13 (Stata Corp, College Station, TX).
RESUlTS
Baseline characteristics of the study population are presented in Table 2. The mean 
age of participants was 64.2 years (SD = 6.6), 13.1% of the study population was highly 
educated and 14.1% were current smokers. The average BMI of the participants was 
27.6 (4.1). 32.3% (n=1790) had prevalent cardiovascular disease (including stroke, MI, 
diabetes, heart failure), 8.2% (n=455) had COPD, 38.4% (n=2126) had joint problems, 
and the average MMSE score was 27.6 (2.2). The total number of person-years in the 
analysis of total mortality was 48,534 person-years (mean follow-up 12.2 years (SE 0.09)), 
during which a total of 2021 participants died.
The spearman’s correlations (correlation coefficient (ρ)) between all subjective well-
being measures are presented in Supplementary table 1. Table 3 shows the hazard 
ratios of all-cause mortality for each determinant of mortality. The proportional hazards 
assumption was met for all associations tested. In the initial model, adjusted for age 
and sex, all subjective well-being indicators were related to mortality. After further 
adjustment for education status, MMSE, blood pressure, total and HDL cholesterol, joint 
problems, cardiovascular factors, prevalent COPD, smoking and alcohol consumption 
(Model 2), higher impairment in BADL (HR per SD = 1.35 (95% CI 1.29 - 1.41)) and IADL 
(HR per SD = 1.27 (95% CI 1.22 - 1.32)) and higher scores on somatic symptoms (HR per 
SD = 1.11 (95% CI 1.06 - 1.16)) and negative affect (HR per SD = 1.05 (95% CI 1.01 - 1.10)) 
were associated with higher all-cause mortality. Correspondingly, higher scores on QoL 
(HR per SD = 0.84 (95% CI 0.81 - 0.88)) and positive affect (HR per SD = 0.92 (95% CI 
0.88 - 0.96)) were associated with lower all-cause mortality.
Further mutual adjustment for each determinant showed that only BADL (HR per SD 
increase in BADL impairment, 1.24 (95% CI 1.16 - 1.32)) and IADL (HR per SD increase in 
IADL impairment, 1.10 (95% CI 1.04 - 1.17)) remained associated with all-cause mortality 
in the mutually-adjusted model (Model 3). The associations of QoL, somatic symptoms, 
negative affect, and positive affect with mortality were strongly attenuated after mutual 
adjustment for each measure of subjective well-being.
Additional analyses (after exclusion of persons with diagnosed major depressive 
disorder at baseline) showed that the association between negative affect and mortal-
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ity were attenuated substantially (supplementary table 2) in the fully adjusted model 
(model 2). The associations of all other subjective well-being measures with mortality 
remained virtually unchanged.
Table 2. Characteristics of the study population.
Characteristics Participants (N = 5538)
Age, years 64.2 (6.6)
Gender (Female), n (%) 3232 (58.4%)
QoL, wS- score 83.4 (42.6)
Education, n (%)
Low 1387 (25.6%)
Intermediate 3326 (61.3%)
High 713 (13.1%)
CES-D Somatic symptoms (scale 0-21) 2.7 (3.1)
CES-D Positive affect (scale 0-12) 9.8 (2.8)
CES-D Negative affect (scale 0-21) 1.4 (2.6)
MMSE, score 27.6 (2.2)
IADL impairment (scale 0-24) 3.0 (3.7)
BADL impairment (scale 0-24) 4.0 (4.3)
Prevalent major depressive disorder 109 (1.9%)
Prevalent stroke 256 (4.6%)
Prevalent MI 388 (7.1%)
Prevalence diabetes 868 (15.7%)
Prevalence COPD 455 (8.2%)
Prevalence heart failure 278 (5.1%)
Alcohol (ever) 4691 (84.7%)
Smoking (current) 778 (14.1%)
Joint problems
Osteoarthritis 1025 (18.9%)
Rheumatoid arthritis 74 (1.4%)
Other joint problemsa 1027 (19.0%)
BMI, kg/m2 27.6 (4.1)
Systolic blood pressure, mmHg 149.6 (21.2)
Diastolic blood pressure, mmHg 79.8 (10.9)
Total cholesterol, mmol/L 5.7 (1.0)
HDL cholesterol, mmol/L 1.4 (0.4)
Values are means (standard deviation) or number of participants (percentage). Abbreviations: n – number of participants; 
QoL– quality of life; wS – weighted satisfaction; CES-D – Center for Epidemiologic Studies Depression scale; MMSE –Mini-
Mental State Examination; IADL – Instrumental Activities of Daily Living scale; BADL – Basic Activities of Daily Living scale; 
MI – Myocardial Infarction; COPD – Chronic Obstructive Pulmonary Disease; BMI – Basal metabolic Rate; HDL – High Den-
sity Lipoprotein aOther joint problems included gout, back pain and ankylosing spondylitis
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DISCUSSIOn
In this large population-based cohort study of 5538 persons (aged on average 64 years), 
2021 persons died during 48,534 follow-up person-years (mean follow-up 12.2 years). In 
this study, all six measures of subjective well-being that include basic and instrumental 
activities of daily living, quality of life, somatic symptoms, negative affect, and positive 
Table 3. The relationship of subjective well-being with all-cause mortality.
All-cause mortality
Measures of subjective well-being per 1-SD* HR per z-score (95% CI)
n/N = 1893/5538
P
Basic activities of daily living Model 1 1.41 (1.35, 1.47) <0.001
Model 2 1.35 (1.29, 1.41) <0.001
Model 3 1.24 (1.16, 1.32) <0.001
Instrumental activities of daily living Model 1 1.35 (1.30, 1.40) <0.001
Model 2 1.27 (1.22, 1.32) <0.001
Model 3 1.10 (1.04, 1.17) 0.001
Quality of life Model 1 0.79 (0.76, 0.83) <0.001
Model 2 0.84 (0.81, 0.88) <0.001
Model 3 0.97 (0.91, 1.03) 0.280
Somatic symptoms Model 1 1.18 (1.13, 1.23) <0.001
Model 2 1.11 (1.06, 1.16) <0.001
Model 3 0.99 (0.93, 1.05) 0.664
negative affect Model 1 1.10 (1.05, 1.14) <0.001
Model 2 1.05 (1.01, 1.10) 0.010
Model 3 1.01 (0.95, 1.07) 0.801
Positive affect Model 1 0.87 (0.84, 0.91) <0.001
Model 2 0.92 (0.88, 0.96) <0.001
Model 3 0.99 (0.94, 1.05) 0.819
SD standard deviation; HR indicates hazard ratio; CI, confidence interval; n, number of persons who died; N, number of 
persons in the total population.
Model 1: Adjusted for age and gender;
Model 2: additionally adjusted for education level, MMSE, joint problems, prevalent stroke, prevalent MI, prevalent dia-
betes mellitus, prevalent COPD, prevalent heart failure, systolic blood pressure, diastolic blood pressure, total cholesterol, 
HDL cholesterol, BMI, smoking, alcohol
Model 3: Model 2 + mutual adjustment for each predictor
*Basic activities of daily living, Instrumental activities of daily living, Somatic symptoms and Negative affect: Higher scores 
indicate greater impairment; quality of life and positive affect: Lower scores indicate greater impairment.
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affect each were related to mortality after adjustment for age, gender, education, cogni-
tion, prevalent chronic diseases, cardiovascular risk factors, and lifestyle factors such 
as BMI, smoking and drinking. After mutual adjustment for each measure of subjective 
well-being were carried out to determine their independent effect on mortality, only 
impairment in physical functioning assessed by either self-report of basic or instrumen-
tal activities of daily living was related to mortality. Further, the association of negative 
affect with mortality was primarily explained by persons with diagnosed major depres-
sive disorder.
In the present study, we observed strong associations of BADL and IADL with mortal-
ity after controlling for educational status, cognition as assessed by MMSE, numerous 
prevalent diseases and several lifestyle factors. Several previous studies have reported 
higher mortality in older people with impairments in basic and instrumental activities of 
daily living.17 18 Higher impairment in BADL may decrease the ability to maintain minimal 
level of physical activity. The loss of independence may ultimately lead to shortened sur-
vival.19 Since impairments in IADL may be due to progressive cognitive decline, this loss 
of independence may be more pronounced in already cognitively impaired persons.20 
There is evidence that neuropathological changes leading to executive and frontal lobe 
dysfunction are related to deterioration in performing BADL and IADL tasks.21 22 There 
is also evidence that limitations in physical functioning have a profound impact on 
mood.23 In particular depression and some somatic diseases exhibit similar symptoms.24 
In one study, the risk of depression on mortality was more pronounced by somatic 
symptoms of depression, rather than cognitive affective symptoms of depression.25 As 
somatic symptoms related to depression are a component of the CES-D questionnaire, it 
can be difficult to assess whether persons with physical dysfunction exhibit depression 
or have somatic comorbidity only. Therefore, we simultaneously tested the association 
of negative affect with mortality. It is well known that depressive symptoms may lead to 
early mortality.26 It is also previously known that patients with major depressive disorder 
have a two-fold increased risk of death than their non-psychotic depressed counter-
parts.27 The mechanisms include physiological changes that adversely affect endocrine, 
neurologic and immune processes.28 29 Conversely, disorders that inhibit daily physical 
function may be responsible for the onset of depressive symptoms, depressive disorders, 
and ultimately mortality. In one study by Blazer and Hybels,30 somatic symptoms and 
negative affect were not associated with mortality; while positive affect was the only 
subscale predicting mortality after controlling for potential confounders. To exemplify, 
in the present cohort another study by Krijthe et al.,31 showed that positive affect was 
associated with survival but the associations were no longer significant once controlled 
for health status. Concurrently, we found that subjective quality of life was related to 
mortality after adjustment for relevant confounding variables in model 2. Quality of life 
combines assessments of perceived physical and mental life satisfaction that contribute 
Chapter 3.1
72
towards overall health into one scale. Ford et al.32 reported higher levels of quality of life 
to be inversely associated with mortality. However, survival was reported without con-
trolling for any prevalent diseases. It follows that the association of mental health with 
mortality is strongly attenuated once perception of physical functioning are carefully 
accounted for. In this context, we may have over-adjusted our associations in the final 
model by controlling for other measures of subjective well-being tested in this study 
that may be inter-related. We argue that this was deliberate; it was our goal to determine 
the independent relation between each subjective well-being measure and mortality 
while other measures of well-being are accounted for. However, if the interest lies in 
the understanding of the association between subjective well-being and mortality in 
general, as in most previous studies, the second model should be considered primarily.
This is the first study to determine the independent association of various measures of 
subjective well-being with mortality. In this study we showed that IADL and BADL have 
an independent relation with mortality after other measures of subjective well-being 
are accounted for. Previously, only few studies have showed an effect of physical func-
tioning independent of other subjective measures.33 34 These findings may have clinical 
implications on risk factor reduction for debilitating diseases that hamper physical 
functioning. Older individuals living in the community, who have impairments in daily 
living tasks, are more vulnerable to health and safety risks within their environment.35 
Thus, these older individuals may be at a higher risk of neglect, mistreatment, exploita-
tion, comorbidity, and decreased survival.36 37 Furthermore, ageing may accelerate the 
inability to compensate functional loss referred to as frailty. A previous study imbedded 
within the Rotterdam Study found an increased risk of death in frail persons compared 
to non-frail elderly persons.38
The strengths of our study include a large sample size and a population-based lon-
gitudinal approach. Most importantly, several instruments were tested. This enabled 
us to investigate the specific associations of somatic symptoms, negative affect, and 
positive affect with mortality above that of other measures of subjective well-being. 
Nearly all participants included in our study had a complete follow-up; there was less 
than 1% loss of person-years. A potential limitation of the current study was the ab-
sence of evaluation of nutritional state of participants. Malnutrition in older adults has 
been linked to mortality, especially the oldest-old with disabilities who are hindered 
in regular functioning of preparing their own meals and are dependent on others for 
their nutritional provisions.39 40 We used BMI as a proxy for nutritional status in order 
to account for malnutrition as previously undertaken in other studies.41 Additionally, 
incident comorbidities occurring in the time period between baseline and death were 
not assessed and could lead to underestimation of our results.
In conclusion, the level of basic activities of daily living and instrumental aspects of 
physical functioning are a prominent independent determinant of mortality in older 
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individuals. Our study suggests that this aspect largely explains the association of sub-
jective well-being and mortality. These findings may have clinical implications for risk 
factor reduction in debilitating diseases that hamper physical functioning. Quality of 
life, somatic symptoms, negative affect and positive affect did not predict mortality 
once self-rated physical functioning is accounted for and may be less optimal screening 
goals. Therefore, interventions aiming at improving survival could focus on subjective 
indicators of physical well-being namely basic and instrumental activities of daily living.
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SUPPlEMEnTARy MATERIAl
Supplementary table 1. Spearman’s correlations (ρ) between study variables.
BADl 
impairment
IADl 
impairment
Quality of 
life
Somatic 
symptoms
negative 
affect
Positive 
affect
BADl impairment 1.000
IADl impairment 0.539 1.000
Quality of life -0.509 -0.381 1.000
Somatic symptoms 0.400 0.243 -0.497 1.000
negative affect 0.272 0.125 -0.395 0.530 1.000
Positive affect -0.318 -0.232 0.497 -0.516 -0.575 1.000
BADL: Basic activities of daily living; IADL: Instrumental activities of daily living; P for all < 0.0001
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Supplementary table 2. The relationship of subjective well-being with all-cause mortality after exclusion 
of persons with major depressive disorder.
All-cause mortality
Measures of subjective well-being, per 1-SD* HR per z-score (95% CI)
n/N = 1968/5429
P
Basic activities of daily living Model 1 1.39 (1.33, 1.45) <0.001
Model 2 1.33 (1.27, 1.39) <0.001
Model 3 1.23 (1.15, 1.31) <0.001
Instrumental activities of daily living Model 1 1.33 (1.28, 1.38) <0.001
Model 2 1.25 (1.20, 1.30) <0.001
Model 3 1.10 (1.04, 1.16) 0.001
Quality of life Model 1 0.80 (0.77, 0.84) <0.001
Model 2 0.86 (0.82, 0.90) <0.001
Model 3 0.97 (0.91, 1.03) 0.294
Somatic symptoms Model 1 1.16 (1.12, 1.21) <0.001
Model 2 1.09 (1.05, 1.14) <0.001
Model 3 0.99 (0.93, 1.05) 0.722
negative affect Model 1 1.07 (1.03, 1.12) <0.001
Model 2 1.03 (0.99, 1.07) 0.155
Model 3 0.99 (0.94, 1.04) 0.669
Positive affect Model 1 0.88 (0.85, 0.92) <0.001
Model 2 0.94 (0.90, 0.98) 0.002
Model 3 0.99 (0.94, 1.05) 0.868
SD standard deviation; HR indicates hazard ratio; CI, confidence interval; n, number of persons who died; N, number of 
persons in the total population.
Model 1: Adjusted for age and gender;
Model 2: additionally adjusted for education level, MMSE, joint problems, prevalent stroke, prevalent MI, prevalent dia-
betes mellitus, prevalent COPD, prevalent heart failure, systolic blood pressure, diastolic blood pressure, total cholesterol, 
HDL cholesterol, BMI, smoking, alcohol
Model 3: Model 2 + mutual adjustment for each predictor
*Basic activities of daily living, Instrumental activities of daily living, Somatic symptoms and Negative affect: Higher scores 
indicate greater impairment; quality of life and positive affect: Lower scores indicate greater impairment.
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ABSTRACT
Background Persons with cognitive impairment, as assessed by cognitive tests, are at 
a higher risk of stroke. Subjective memory complaints might be an earlier marker for 
stroke, especially in persons with higher education. Their cognitive reserve might mask 
their cognitive impairment during cognitive testing. In a population-based setting, we 
investigated the association between subjective memory complaints and stroke. We 
simultaneously investigated the association between Mini-Mental State Examination 
(MMSE) and stroke. We also assessed whether these associations varied with educational 
level.
Methods 9,152 participants from the Rotterdam Study (baseline 1990-1993 or 2000-
2001) completed the subjective memory complaints questionnaire and underwent 
MMSE assessment. Subsequently, the entire cohort was followed for incident stroke un-
til 2012. We used Cox proportional hazard models to estimate the associations between 
subjective memory complaints and MMSE, with stroke.
Results During a follow-up of 111,593 person years, 1,134 strokes were identified, of 
which 663 were ischemic and 99 hemorrhagic. In the fully adjusted model, presence of 
subjective memory complaints was independently associated with a higher risk of stroke 
(hazard ratio [HR] 1.20 (95% confidence interval (CI) 1.04-1.39), but a higher MMSE was 
not (HR per point increase 0.99 (95% CI 0.95 - 1.02)). The association between subjective 
memory complaints and risk of stroke was modified by educational level, with a higher 
risk of stroke in persons with a higher level of education (HR 1.39 95% CI 1.07 - 1.81).
Conclusions Subjective memory complaints might be an early indicator of stroke risk 
especially in highly educated individuals.
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InTRODUCTIOn
Cognitive impairment and dementia are very often long-term sequelae of stroke.1 This 
could be due to direct loss of brain parenchyma during stroke, especially when such 
damage is located at strategic sites in the brain, for instance in the thalamus.2 However, 
cognitive impairment and stroke might also be linked through a shared etiology as vas-
cular risk factors for stroke are also determinants of cognitive impairment and demen-
tia.3, 4 To test this hypothesis, several studies that investigated how cognitive impairment 
relates to incident stroke were reviewed, and found an increased risk of stroke in persons 
with lower cognitive performance.5
Most studies have used objective cognitive tests, such as the Mini-Mental State 
Examination (MMSE), to determine the presence of cognitive impairment.6-9 However, 
subjective memory complaints may appear earlier and might therefore be an earlier 
marker of vascular damage that could also lead to stroke.10 This may apply especially to 
persons with higher education, who perform well on cognitive testing, probably due to 
a higher cognitive reserve,11 which can mask subtle changes in cognition. As a result, 
these persons may continue to harbor subclinical vascular insults to the brain. Previous 
studies have found an association between subjective memory complaints and risk of 
dementia,12, 13 mostly in persons with higher education.11 Still, the clinical importance of 
subjective memory complaints for the prediction of stroke remains unclear.
The aim of the present study was to evaluate the independent association between 
subjective memory complaints and the risk of stroke. In addition, we used the MMSE 
as an objective measure to relate with incident stroke. Furthermore, we also sought to 
determine whether these associations vary with educational level.
METHODS
Study Population
This study was embedded in the Rotterdam Study, a large prospective population-based 
cohort that started in 1990 among inhabitants aged ≥55 years residing in a district of 
Rotterdam, the Netherlands (N=7,983). An expansion of the cohort took place in year 
2000, consisting of 3,011 participants who had become 55 years of age or moved into 
the study district since the start of the study.14 The Rotterdam Study has been approved 
by the medical ethics committee according to the Population Study Act Rotterdam 
Study, executed by the Ministry of Health, Welfare and Sports of the Netherlands. A writ-
ten informed consent was obtained from all participants. For the present study, after 
exclusion of participants at baseline with prevalent stroke (n=291), prevalent dementia 
(n=437), prevalent dementia and stroke (n=74) and no informed consent for data linkage 
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(n=151), 9152 participants with data on subjective memory complaints were eligible for 
analysis (Supplementary figure 1).
Assessment of Subjective Memory Complaints and Objective Cognition
Trained investigators interviewed all participants at home. The presence of subjective 
memory complaints was assessed by the question, “Do you have memory complaints?”11
Cognitive function on an objective scale was tested with the 30-point Mini-Mental 
State Examination (MMSE).15 The MMSE contains 20 items covering orientation, memory, 
attention, language, and visuospatial construction.
Assessment and follow-up of Stroke
At study entry, history of stroke was assessed using home interviews and confirmed by 
reviewing medical records. Once participants entered the Rotterdam Study, they were 
continuously followed up for stroke through automatic linkage of general practitioner 
files with the study database. Also, nursing home physicians’ files and files from general 
practitioners of participants who moved out of the district were checked on a regular 
basis. Of the potential strokes, additional hospital and general practitioner information 
was collected. Research physicians reviewed the stroke information, and an experienced 
neurologist adjudicated the strokes using standardized definitions, as described in de-
tail previously.16 The follow-up was complete until January 1, 2012, for 97% of potential 
person-years.
Assessment and follow-up of dementia
Participants were screened for dementia at baseline and follow-up examinations using 
a three-step protocol. Screening was done using the Mini-Mental State Examination 
(MMSE) and the Geriatric Mental Schedule (GMS) organic level.17, 18 Screen-positives 
(MMSE <26 or GMS organic level >0) subsequently underwent an examination and 
informant interview with the Cambridge Examination for Mental Disorders in the Elderly 
(CAMDEX).19 Participants who were suspected of having dementia, underwent, if neces-
sary, further neuropsychological testing. Additionally, the total cohort was continuously 
monitored for dementia through computerized linkage between the study database 
and digitized medical records from general practitioners and the Regional Institute 
for Outpatient Mental Health Care. When information on neuro-imaging was required 
and available, it was used for decision making on the diagnosis. For all suspected cases 
of dementia, a consensus panel, led by a neurologist, decided on the final diagnosis 
in accordance with standard criteria for dementia (DSM-III-R) and Alzheimer’s disease 
(NINCDS-ADRDA).20, 21Follow-up for incident dementia was virtually complete until 
September 2, 2011.
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Measurement of covariates
We used covariates measured at baseline. Smoking status and information on the number 
of cigarettes smoked per day in each decade of life was obtained by a self-administered 
questionnaire during the home interview. Smoking status was characterized as never, 
past and current smoking. Participants were also invited to visit the research centre for 
clinical examinations and laboratory assessments. Body mass index (BMI) was measured 
using weight in kilograms divided by the square of height in meters. Total cholesterol and 
HDL-cholesterol levels were acquired by an automated enzymatic procedure. Diabetes 
mellitus type-2 was defined as having a fasting glucose level of ≥7.0 mmol/L or using 
blood glucose–lowering medication. Blood pressure was measured at the research cen-
ter twice in the sitting position on the right arm with a random zero sphygmomanom-
eter. The average of the two measurements was used in the analyses. Data on indication 
for use of blood pressure-lowering medication were based on information collected by a 
physician at the research centre. In the case of missing information, data from the home 
interview was taken. Information on APOE-ε4 genotype (at least one APOE-ε4 allele vs. 
no APOE-ε4 alleles) was determined from blood samples. Basic Activities of Daily Living 
(BADL) was assessed using the Dutch version of the disability index from the Stanford 
Health Assessment Questionnaire.22 The disability index consists of 20 items constitut-
ing eight components: dressing and grooming, arising, eating, walking, hygiene, grip, 
reach, and activities. Two of the three items belonging to the eating component were 
combined into one item. Each item was scored from 0 to 3, with higher scores indicating 
worse ability: 0 = without any difficulty, 1 = with some difficulty, 2 = with much difficulty, 
3 = unable to.23
Statistical Analysis
We investigated the associations of subjective memory complaints and MMSE, as a 
continuous measure, with stroke incidence using Cox proportional hazards models. 
The proportional hazard assumption was evaluated using Schoenfeld residuals.24 The 
underlying time-scale in these models was the follow-up time in years. Participants who 
did not suffer from stroke were censored at date of death, date of loss to follow-up, or 
January 1, 2012, whichever occurred first. All models were adjusted for age, sex, and 
cohort. We subsequently adjusted for BMI, diabetes mellitus type-2, smoking status, 
systolic blood pressure, diastolic blood pressure, blood pressure lowering medication, 
total serum cholesterol, HDL-cholesterol, lipid lowering medication, BADL, APOE-ε4 
allele carrier status, and MMSE or subjective memory complaints (where applicable). To 
examine whether subclinical subjective memory complaints are associated with stroke, 
two sensitivity analyses were performed: first, we censored for incident dementia during 
follow-up. Second, we additionally excluded participants with a MMSE score of <26 at 
baseline.25
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To investigate whether education level affected the association between subjective 
memory complaints and MMSE with stroke, we constructed interaction terms with 
education and performed stratified analyses. We categorized level of education into 
three groups: low education (primary education only), intermediate education (primary 
education plus a not completed higher education, lower vocational education, inter-
mediate vocational education, or general secondary education), and high education 
(higher vocational education or university training).
Missing values on blood measurements were due to failure of blood draw or the blood 
sample was inadequate to run all tests. Blood pressure measurements and anthropom-
etry measures were missing due to physical inability of persons. Respective questions 
on smoking status, education level, use of medication were missing due to time con-
straints in administering the questions at the time of home interview. Missing values 
for the confounding variables (0.1 – 5.8% missing data) (supplementary figure 1) were 
imputed by multiple imputation using chained equations in which 40 completed data 
sets were generated and analyzed by using the standard combination rules for multiple 
imputation. Each variable was used as a predictor in the imputation model. All continu-
ous variables in our data had normal distribution. No interactions were included in the 
final analysis thus no interactions were included in the imputation models. The data was 
imputed assuming that the data was missing at random. All analyses were performed 
using Stata13 (Stata Corp, College Station, TX).
RESUlTS
Baseline characteristics of the study population are presented in Table 1. Individuals with 
any missing data on covariates (n=999) were compared with persons with complete data 
(n=8153); Persons with incomplete data were older in age (72.2 years (10.2) compared to 
67.1 years (8.4), P<0.001), were more often female (63.8% compared to 57.6%, P<0.001), 
had more complaints about their memory (23.7% compared to 16.1%, P<0.001), and had 
0.5 point lower score on MMSE (27.3 (2.2) compared to 27.7 (1.8)).
During 111,593 person-years (mean follow-up 12.2 years), 1,134 incident strokes were 
reported; 663 of these were ischemic and 99 were hemorrhagic. A total of 372 cases 
remained unspecified, mostly because they were not referred to the hospital and hence 
did not undergo brain imaging. 2668 persons had incomplete amount of person-years 
until 2012; whose last date of contact was before the potential end-date if there was no 
loss to-follow-up. In addition, 3793 persons had died during follow-up.
Table 2 shows hazard ratios for the associations of subjective memory complaints 
and MMSE, with total, ischemic, and hemorrhagic stroke. The proportional hazards as-
sumption was met for all associations tested. After adjusting for age, sex, and education, 
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presence of subjective memory complaints was associated with a higher risk of stroke, 
hazard ratio (HR) 1.19 (95% CI 1.03 - 1.38). The association between subjective memory 
complaints and stroke did not change significantly after adjustment for lifestyle factors, 
vascular risk factors, and APOE-ε4 and MMSE, HR 1.20 (95% CI 1.04 - 1.39). The association 
between subjective memory complaints and ischemic stroke was similar in strength, HR 
1.22 (95% CI 1.01 - 1.49) in the fully-adjusted model.
An increase in MMSE score was not significantly associated with the risk of stroke: fully 
adjusted HR per point higher MMSE score 0.99 (95% CI 0.95 - 1.02). The effect sizes for 
the association between MMSE with ischemic and hemorrhagic stroke were also non-
significant. Mutual adjustment (model 2) showed that subjective memory complaints 
was associated with stroke independently of MMSE. Additional analyses (censoring at 
Table 1: Baseline characteristics of the study population
Participants
(N=9152)*
SMC=no
(N=7600)
SMC=yes
(N=1552)
Age (years) 67.1 (8.5) 70.3 (9.4)
Female 4368 (82.0%) 962 (18.1%)
Education
High 2315 (30.9%) 428 (28.3%)
Intermediate 3852 (51.3%) 699 (46.2%)
Low 1338 (17.8%) 386 (25.5%)
Systolic blood pressure (mmHg) 140.4 (22.0) 139.8 (22.7)
Diastolic blood pressure (mmHg) 75.5 (11.5) 74.3 (11.9)
Use of blood pressure lowering medication 2246 (29.6%) 511 (33.0%)
Total cholesterol (mmol/L) 6.4 (1.2) 6.4 (1.3)
HDL-cholesterol (mmol/L) 1.4 (0.4) 1.4 (0.4)
Use of lipid lowering medication 394 (5.2%) 72 (4.7%)
Diabetes mellitus 760 (10.0%) 165 (10.7%)
Smoking 1721 (22.8%) 285(18.7%)
Never 2558 (33.7%) 592 (38.1%)
Past 3321 (43.7%) 675 (43.5%)
Current 1721 (22.6%) 285 (18.4%)
Body mass index (kg/m2) 26.6 (3.8) 26.4 (3.8)
Basic Activities of Daily Living (impairment score) 0.3 (0.5) 0.5 (0.6)
MMSE score 27.8 (1.8) 27.3 (2.1)
APOE-ε4 allele carriers 1948 (27.2%) 440 (30.4%)
Values are means (standard deviation) or number of participants (percentage).
*291 participants with prevalent stroke excluded at baseline; 437 participants with prevalent dementia excluded at base-
line; 74 participants with both prevalent stroke and prevalent dementia excluded at baseline; 151 excluded with no in-
formed consent for data linkage.
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the date of diagnosis of incident dementia, and excluding persons with MMSE < 26 at 
baseline) showed virtually unchanged results.
We found a significant interaction between the level of education and subjective 
memory complaints in relation to stroke (P=0.007). The education-stratified analyses 
showed that subjective memory complaints were significantly associated with stroke 
only in persons with high education, HR 1.39 ((95% CI 1.07 - 1.81) fully adjusted); Table 
3 and Figure 1). Time to incident stroke was also shorter in persons with high education 
level who complained about their memory (Figure 1). The effect sizes of MMSE with 
stroke were similar across the strata of education.
Table 2. Subjective memory complaints, Mini-Mental State Examination (MMSE) and risk of incident stroke.
Total strokes Ischemic strokes Hemorrhagic strokes
HR (95% CI) HR (95% CI) HR (95% CI)
Total population n/N=1134/9152 n/N=663/9152 n/N=99/9152
Subjective memory complaints (yes 
vs no)
Model 1 1.19 (1.03, 1.38) 1.17 (0.96, 1.42) 1.32 (0.81, 2.15)
Model 2 1.20 (1.04, 1.39) 1.22 (1.01, 1.49) 1.39 (0.85, 2.26
MMSE (per point increase) Model 1 0.97 (0.94, 1.00) 1.02 (0.98, 1.07) 0.96 (0.86, 1.07)
Model 2 0.99 (0.95, 1.02) 1.04 (0.99, 1.09) 0.97 (0.87, 1.09)
Censoring for dementia n/N=1000/9152 n/N=630/9152 n/N=91/9152
Subjective memory complaints (yes 
vs no)
Model 1 1.17 (1.00, 1.37) 1.15 (0.94, 1.41) 1.35 (0.81, 2.25)
Model 2 1.19 (1.01, 1.39) 1.20 (0.98, 1.47) 1.42 (0.85, 2.37)
MMSE (per point increase) Model 1 0.98 (0.95, 1.02) 1.01 (0.97, 1.06) 0.95 (0.85, 1.07)
Model 2 0.99 (0.96, 1.03) 1.02 (0.98, 1.07) 0.97 (0.86, 1.09)
Censoring for dementia and excluding 
MMSE<26
n/N=891/8200 n/N=577/8200 n/N=82/8200
Subjective memory complaints (yes 
vs no)
Model 1 1.17 (0.99, 1.39) 1.14 (0.92, 1.41) 1.33 (0.77, 2.31)
Model 2 1.20 (1.02, 1.42) 1.19 (0.96, 1.48) 1.39 (0.80, 2.41)
MMSE (per point increase) Model 1 0.99 (0.93, 1.04) 1.01 (0.94, 1.08) 1.00 (0.83, 1.20)
Model 2 1.00 (0.95, 1.06) 1.02 (0.95, 1.10) 1.02 (0.85, 1.23)
CI indicates confidence interval; HR, hazard ratio; n, number of stroke events; and N, number of persons in the total popula-
tion.
Model 1: Adjusted for age, sex, education, and cohort
Model 2: Model 1 + BMI, diabetes, smoking, systolic blood pressure, diastolic blood pressure, blood pressure lowering 
medication, total serum cholesterol, HDL-cholesterol, lipid lowering medication, and APOE-ε4, basic activities of daily liv-
ing, and MMSE or subjective memory complaints
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DISCUSSIOn
We found that individuals with subjective memory complaints, especially those with a 
high level of education, had an increased risk of stroke compared with those who did not 
complain about their memory. The association between subjective memory complaints 
and stroke was independent of the MMSE score. All associations remained similar after 
censoring for incident dementia and further excluding persons with an MMSE score <26 
at baseline.
Subjective memory complaints are common in the elderly with prevalence rates 
reported from 11% in persons above 65 years to 88% in those aged above 85 years.26, 27 
In our population of community-dwelling individuals of on average age 67 years, the 
prevalence was 17% and is very comparable to numbers in the literature.
The associations between subjective memory complaints and the risk of stroke are 
probably mainly explained by shared vascular risk factors. Subjective memory com-
plaints may be a marker of cerebral microvascular injuries which may ultimately lead to 
clinical stroke.5 Previous studies have found associations between subjective memory 
complaints and cerebral microbleeds or white matter lesions.28, 29 This supports our hy-
pothesis that early vascular damage presenting as memory complaints, which are not 
yet evident in cognitive tests, may in future lead to clinical stroke. Similarly, it has been 
shown among hypertensive patients that those with subjective memory complaints 
have more arterial stiffness and white matter lesions than patients without subjective 
memory complaints.30 One study showed the presence of amyloid-β protein deposition 
in people with subjective memory complaints, who were otherwise cognitively unim-
paired (MMSE ≥28). Yet in the same study, no association was found between objective 
memory measures and amyloid burden.31 Thus, the deposition of amyloid-β proteins in 
the vessels of the brain can compromise their integrity, which may lead to leakage and 
subsequently contribute to clinical stroke.32
figure 1. Kaplan-Meier cumulative incidence curves of total strokes in (A) low educated, (B) intermediate 
educated and, (C) highly educated persons with or without subjective memory complaints.
Figure 1. Kaplan-Meier cumulative incidence curves of total strokes in (A) low 
educated, (B) intermediate educated and, (C) highly educated persons with or 
without subjective memory complaints. 
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We found that the association between subjective memory complaints and stroke 
was strongest in highly educated persons. This is comparable to a previous finding 
that the association between subjective memory complaints and Alzheimer’s disease 
is strongest in highly educated persons.11 An explanation may be that persons who are 
highly educated are more likely to notice subtle changes in their cognitive performance 
than the less educated. This makes the perception of memory changes of highly edu-
cated persons a suitable measure to assess subtle cerebrovascular degeneration. This is 
evident in our data after adjustment for age, sex and MMSE at baseline, we found that 
the odds of having subjective memory complaints is 1.56 times in the high education 
group compared to low education group. A counter-argument against this reasoning 
is that in our population, memory complaints were more frequent in the low educated 
group compared to the highly educated group. Another explanation is that education 
reflects cognitive reserve.33 Higher cognitive reserve allows persons to cope better with 
accumulating vascular injury in the brain, thereby maintaining their performance on 
cognitive testing. Subjective memory complaints in these highly educated persons 
might therefore be a better marker than cognitive testing to assess vascular brain injury.
The strengths of our study are its population-based prospective design and avail-
ability of data on more than 9000 participants at baseline with a long follow-up. The 
main novelty of our study is that we describe subjective memory complaints in addition 
to objective cognitive testing as an independent predictor of stroke. Furthermore, we 
also assess the association between subjective memory complaints and stroke in a 
population without stroke and dementia at baseline.5 Our study is limited by the use 
of MMSE as the only comparative objective measure of cognitive impairment because 
the severity of cognitive impairment cannot be reliably assessed by MMSE alone. Future 
studies with more extensive cognitive testing batteries are needed to determine the 
associations between cognitive impairment and stroke. Since different cognitive tests 
target different cognitive domains, it would be mandatory to apply a variety of objec-
tive measurements to determine which cognitive domains are particularly associated 
with a higher risk of stroke. Our study is limited by the unavailability of neuro-imaging 
data. Future studies should include MRI findings to explore the evidence of small vessel 
disease as an underlying mechanism of the associations between subjective memory 
complaints and stroke. Among the 372 unspecified strokes, silent strokes were not diag-
nosed since all strokes being clinical strokes were reported at the hospital. Furthermore, 
although we adjusted for a variety of vascular risk factors, we cannot exclude residual 
confounding by measurement error or unmeasured factors. Moreover, the covariates in 
our list may not be exhaustive of all vascular risk factors and there may also be some risk 
factors that do not go through the vascular risk factor pathways. The unavailability of 
data on depression and/or depressive symptoms as an unmeasured confounder is also 
a major limitation of this study since it has been suggested that the associations with 
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subjective indicators of health especially memory may be confounded by prevalence of 
depression.34
In conclusion, subjective memory complaints are associated with a higher risk of 
incident stroke, especially in persons with a high level of education. In these persons, 
cognitive tests are not of incremental value, since they might perform well despite their 
subjective memory dysfunction. This suggests the importance of a single self-rated 
question about memory complaints that can prompt clinicians to consider screening for 
and treatment of vascular risk factors. People with high level of education who complain 
about changes in their memory should be a primary target for further risk factor screen-
ing and prevention of stroke.
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ABSTRACT
Background The cognitive reserve hypothesis suggests that across the lifespan higher 
education, regular participation in social or mentally stimulating activities and com-
plexity of occupation increase an individual’s resistance to dementia. However, there is 
currently no consensus regarding how to assess or measure cognitive reserve.
Method We performed a systematic review of reviews focused on the concept of 
cognitive reserve to examine key elements of the definition and highlight limitations. 
We searched Embase.com, MEDLINE (OvidSP), the Cochrane Library, Web of Science, 
Scopus, Google Scholar and PubMed.
Results Five systematic reviews were identified. These incorporated findings from 
cohort, cross-sectional and case-control studies and the outcomes examined included 
Alzheimer’s disease, vascular dementia, non-specified dementia, all dementias and cog-
nitive decline or cognitive impairment. Education, occupation and leisure or mentally 
stimulating activities were suggested to supply cognitive reserve and offer a protective 
effect against the risk of dementia. Premorbid IQ and socioeconomic status have not 
been investigated as thoroughly and showed inconsistent results. Two of the reviews 
showed that when combining different indicators in the analyses/definition, including 
education, occupation, mentally stimulating activities and premorbid IQ, cognitive 
reserve had a protective effect against cognitive decline. However, other indicators may 
also supply the reserve, including dietary habits and genetic indicators, but research is 
lacking with regards to creating a full cognitive reserve model.
Conclusions This review highlights the lack of consensus regarding a definition of cog-
nitive reserve. Further research is required to clarify how the indicators already identified 
may provide cognitive reserve and offer a protective effect against dementia. Agreement 
on the indicators that constitute the cognitive reserve model is needed before testing 
possible interventions which may increase the reserve supply and improve cognition.
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InTRODUCTIOn
The reserve hypothesis attempts to explain the neuropathological findings of advanced 
Alzheimer’s disease pathology (e.g., amyloid-β plaques and neurofibrillary tangles) at 
autopsy which have been found in individuals who have remained cognitively healthy 
throughout their lives1. Further, individuals with equivalent levels of Alzheimer’s disease 
pathology have shown differences in timing of dementia onset with some individuals 
having a shorter duration of the disease before death1. These findings suggest that some 
adults can endure the pathological changes related to Alzheimer’s disease better than 
others, a concept known as cognitive resilience2. The explanation for the inconsistency 
between pathological damage and clinical expression of disease in different individu-
als is currently unclear, but the reserve hypothesis aims to fill this gap. Indeed, much 
research has focused on the various indicators which may contribute towards supplying 
the reserve3. Previous reviews have discussed the reserve hypothesis, however, there 
is a need for a review of these in order to pull together the concepts identified in the 
different reviews with the aim of arriving at consensus on how best to define reserve.
The reserve hypothesis can be broadly split into two concepts, brain and cognitive 
reserve. Cognitive reserve is an active model, which suggests that individuals differ in 
how the individual manages brain damage using protective mechanisms associated 
with cognitive abilities built up over the life course, and also via actively producing com-
plex responsive processes to compensate for the damage caused by disease processes4. 
This has two components, neural reserve (the capabilities of the brain prior to damage) 
and neural compensation (using areas of the brain which were not previously used to 
compensate for damage)5. In the active model of cognitive reserve, certain experiences 
throughout the life course such as higher education, engagement in leisure activities 
and occupational attainments do not only increase cognitive ability, but also supply 
the cognitive reserve which may reduce the risk of dementia in old age3. Alongside the 
concept of cognitive reserve is the concept of brain reserve6. In contrast to cognitive 
reserve, brain reserve refers to a passive model of reserve, whereby a larger brain size 
or a larger number of neurons form the substrate7-9. Brain reserve is deemed passive 
as it implies that individuals only differ in the volume of their brain matter. It does not 
consider that individuals have differing cognitive abilities, which may lead to different 
outcomes from Alzheimer’s disease pathology and other brain damage7. The concepts 
are not mutually exclusive. For example, a higher cognitive reserve could potentially 
lead to a protective mechanism, which results in less neuronal loss, and they may both 
contribute to the overall supply to reserve and assist the brain in minimizing the ef-
fects of brain pathology. However, whether the indicators of cognitive and brain reserve 
interplay remains unclear and has led to difficulty in differentiating between the two 
concepts2.
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Educational attainment, amongst other factors, has been proposed to contribute to 
cognitive reserve and has been a focus of much of the work regarding cognitive reserve 
in human studies. Several studies in older adults have shown slower rates of cognitive 
decline and a decreased risk of dementia amongst those with higher levels of educa-
tion7,10.
Various other indicators have also been linked to higher cognitive ability, such as occu-
pational attainment, leisure activities and social engagement. However, currently there 
is no standard definition for cognitive reserve and, therefore, the indicators thought to 
contribute to cognitive reserve, and their weighted contribution to cognitive reserve, 
have not been adequately defined. This creates difficulty in comparing different studies 
of cognitive reserve and leads to heterogeneity across study designs. Additionally, there 
are issues with timing, as the cognitive reserve may incorporate numerous indicators 
across the life course from early life indicators, such as indicators relating to levels of 
education, to later life indicators, such as indicators relating to occupation. Further, 
there are indicators which continue throughout life, such as social engagement, which 
also have various proxy measures. Studies of cognitive reserve also tend to be limited 
to the data collected. For instance, degree of literacy has been suggested to be a better 
measure of cognitive reserve than number of years of education, yet few studies have 
collected this indicator and, therefore, years of education is more often used9.
Although there has been considerable research into which factors contribute to 
reserve, the validity of the reserve hypothesis as an independent construct separate 
from other cognitive concepts has been questioned and is still under debate5. A study 
which evaluated the construct validity of cognitive reserve concluded that the concept 
had strong convergent validity and moderate discriminant validity, and could be ap-
propriate to refer to cognitive reserve as a unique cognitive concept, but this may be 
limited to executive processing5. However, to further research the validity of the concept 
of reserve, identifying which factors contribute to the definition of reserve is essential.
The aim of this review is to pull together the existing literature regarding cognitive 
reserve and brain reserve and ascertain if there are any common elements, which may 
be key contributing indicators. Further, this work could contribute to future models of 
cognitive reserve, which could help to determine the indicators that may be the most 
important for defining cognitive reserve.
METHODS
Search strategy
We performed a systematic literature search in electronic databases. The online search 
strategies were designed and executed by the second author (AS) and an experienced 
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medical librarian (WMB). The search results were not restricted to articles using a phrase 
related to cognitive or brain reserve, but searched broader for prevention of cognitive 
impairment by cognitive training. A combination of controlled search terms (MeSH 
terms in MEDLINE and emtree terms in Embase) and words in title or abstract was used 
to search Embase.com, MEDLINE (OvidSP), the Cochrane library, Web of Science, Scopus, 
Google Scholar, and PubMed for recent articles added by the publisher. The search 
was last executed on November 10, 2014. Potentially eligible studies included English 
language systematic review articles on the concept of cognitive and brain reserve and 
how it has been mapped in population studies.
Scope of the Review
Cognitive reserve is defined as: “Innate intelligence or aspects of life experience like 
educational or occupational attainments that may supply reserve, in the form of a set 
of skills or repertoires that allows some people to cope with progressing Alzheimer’s 
disease pathology better than others”3. Overlapping this concept is the concept of brain 
reserve, which adds indicators such as brain size and synaptic count, which may supply 
the overall reserve and account for some differences between individual outcomes to 
brain damage. As the aim was to gain a more comprehensive overview of the indicators 
of cognitive reserve, any systematic review articles which focused on the concept of 
cognitive reserve or brain reserve were eligible for inclusion.
Article Selection
Two reviewers (AS and SLH) independently screened the titles and abstracts of the 
initially identified studies for their potential eligibility. Full-text versions of the identified 
studies were then screened using the selection criteria for final inclusion. An overview 
of the selection of studies and full eligibility criteria is presented in Figure 1. We also 
cross-referenced the selected studies to identify additional relevant studies.
Data collection and analysis
Using a pre-defined data collection form the following information was extracted from 
each paper: the number of studies reviewed, search date, sample size, age range of 
the included participants in the review articles, follow-up time, indicator of cognitive 
reserve identified such as education, occupation, lifestyle, mental activities, premorbid 
IQ etc., differentiation of the indicators of brain reserve (where differentiated), summary 
measures if meta-analyses were performed, limitations, suggestions for future research 
and the implications/conclusions of the concept of cognitive reserve in each review 
article. Summary statistics (if reported in a meta-analysis) were compared across studies.
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figure 1. Flow diagram of included studies
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(N = 1902)
Articles excluded on the basis of titles and abstracts
No relevant exposure (concept of cognitive reserve) dened - 965
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Animal studies - 67
Not review articles - 289
Inappropriate study populations - 320
(N = 1764)
Full-texts retrieved for 
further detailed 
evaluation
(N = 138)
Full text articles excluded
Full texts in languages other than English– 9
Not review articles – 14
Concept of cognitive reserve not dened – 24 
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Articles unavailable* – 2
(N = 103)
Review articles on the 
concept of cognitive 
reserve and its implications 
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(N = 37)
Systematic reviews 
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RESUlTS
number of studies
Searches of the different online databases stated previously resulted, after removing 
duplicate entries, in 1902 potentially relevant citations. After independent reviewing of 
titles and abstracts by two authors, 1764 articles were excluded, the main reasons for 
exclusion at this stage were no concept of cognitive reserve defined (N=965) and that 
they were not full reviews i.e. letters, abstracts, conference proceedings or editorials 
(N=123), further reasons for exclusion are shown in Figure 1. The full-text of 138 articles 
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were retrieved and further evaluated in more detail. In total, five articles were systematic 
reviews which were included in the results section of this review10-14. Furthermore, 32 
papers were excluded as they were narrative reviews and were only to be used in the 
introduction and discussion. Other reasons for exclusion at the full-text review stage 
were that the studies were not review papers, the concept of cognitive reserve not 
defined; inappropriate baseline population (patient populations with multiple sclerosis, 
brain injury, Parkinson’s disease, HIV etc) and articles being unavailable.
Characteristics and focus of included reviews
Table 1 shows the characteristics of the five systematic reviews included. Four of the five 
reviews also included a meta-analysis of results10,12-14. The number of articles included 
in the individual reviews ranged from 1812 to 6910. Sample sizes of the original articles 
ranged from 28 to 2332910. The outcomes of the reviews were wide-ranging (e.g., 
Alzheimer’s disease, vascular dementia, non-specified dementia, all dementias and 
cognitive decline or cognitive impairment). There was a mixture of cohort studies and 
cross-sectional studies based on the general population and case-control studies which 
has cases of with different types of dementia compared against healthy controls. Three 
of the systematic reviews included studies that were of a case-control, cohort or cross-
sectional design10,11,14, and two of the systematic reviews included only longitudinal 
cohort studies12,13. Follow-up years were not given in two reviews10,14, and ranged in the 
other three reviews from 111 to 45 years12. The number of indicators of cognitive or brain 
reserve investigated varied from one indicator10,14 to five indicators11; also, the indicators 
investigated varied, as did the definitions used for the indicators (e.g., mentally stimulat-
ing activities or complex leisure activities were similar, but had different categorization 
criteria). Further, the reviews differed as to whether they only analyzed cognitive reserve 
(N=3)10,11,14 or used the term brain reserve (N=2)12,13.
Quality of the systematic reviews
The quality of included studies was evaluated using the measurement tool to assess 
systematic reviews (AMSTAR) criteria15. Each review was individually assessed against 
the set criteria, which comprises of eleven questions focused on scientific quality of 
included studies assessed and if the methods used to combine findings of the study 
were appropriate. <5 points indicates low review quality, 5 to 8 points indicates moder-
ate review quality and >8 points indicates high review quality. The majority of studies 
scored low on assessment of review quality (4 reviews scored 4 points on the AMSTAR 
checklist), and only one review met the AMSTAR criteria for moderate systematic review 
quality (one review scored 7 points)10. The main reasons for scoring points were having 
a comprehensive literature search and detailing characteristics of the studies provided. 
None of the studies gained points for detailing conflicts of interest, assessing and docu-
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menting the scientific quality of included studies, providing a list of included and ex-
cluded studies or providing an ‘a priori’ design. Further, the meta-analyses results varied 
for what outcome was tested (Alzheimer’s disease, vascular dementia, any dementia, 
non-Alzheimer’s dementia, cognitive decline or cognitive impairment) and also the test 
statistic generated (odds ratios, risk ratios or φ).
Description by possible indicators of cognitive and brain reserve
Education
Education was the only reserve indicator investigated in all five of the systematic re-
views, and was analyzed both in relation to cognitive and to brain reserve. The results of 
the meta-analyses found a lower level of education to be significantly associated with 
an increased risk of Alzheimer’s disease, vascular dementia, any dementia or cognitive 
decline. Definitions for ‘high’ levels of education varied across studies, as did definitions 
for the reference category, i.e. some studies used low levels of education and some used 
all participants except those with high levels of education. Although degree of literacy 
is thought to be a better measure of educational attainment9, this was scarcely used 
across included studies, with years of education being far more extensively studied. Yet, 
all studies concluded that the results of the review indicated that a low level of educa-
tion was a risk factor for dementia, cognitive decline or cognitive impairment. Only one 
of the reviews systematically examined pathology and neuroimaging studies10, and 
this was a review which only examined education as an indicator for cognitive reserve. 
This review reported that out of 14 imaging studies investigated, 10 studies reported 
an increased level of degradation and pathology amongst those with higher levels of 
education. This is in line with the idea that those with higher levels of education have 
the ability to cope with greater levels of brain pathology before experiencing symptoms 
of the disease.
Occupation
Occupational attainment was only investigated in two meta-analyses12,13, and work com-
plexity was investigated in one systematic review11. The results from the meta-analyses 
conflicted, as one meta-analysis found occupation to be significantly associated with an 
increased risk for incident dementia13, whereas, the other did not find any association 
between occupation attainment and changes in cognition12. Variability between results 
may be due to the use of different categorizations to describe occupational attainment 
(e.g., low occupation was described as house duties, farmers, domestic, blue collar in 
one article16 and unskilled, semi-skilled, housewife in others17,18). Further, the different 
outcomes assessed and different controls for confounding indicators (e.g., age, gender, 
education) may have led to the inconsistencies in results. Also, across all the reviews 
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which investigated occupation, different terms were used in the definition (e.g., work 
complexity or occupation).
Leisure activities
Leisure activities is a very broad phrase for what could include many different and 
diverse activities, which could be stimulating mentally, socially, physically or via a 
combination of these. Three review articles described leisure activities as a potential 
indicator of cognitive reserve11-13. One review concluded that leisure activities was a 
more robust measure of brain reserve compared to premorbid IQ, education and oc-
cupation, as increased involvement in leisure activities throughout life was significantly 
associated with a reduced risk of incident dementia in all of the studies investigated 
even after controlling for confounding factors (e.g., age, occupation, education)13. One 
review emphasized that previous studies which investigated leisure activities in relation 
to incident dementia have been heterogeneous with regard to both study design and 
types of activities studied, yet, despite this lack of comparability; the majority of stud-
ies reported an association between increased participation in leisure activities and a 
reduced risk of developing dementia11. All of these reviews highlighted that the leisure 
activities should be “mentally stimulating”, and one review went further to conclude that 
activities which are more complex, such as those which combine physical, social and 
mentally stimulating aspects, appear to have the most benefit in the protection against 
dementia onset11. Many of the included studies within the reviews suggested that any 
sort of mentally stimulating activity would have to be partaken on a regular basis to 
have a positive effect, although they differed as how to define regular involvement 
(e.g., >3 times a month or >3 times a week).
Social networks
Two review articles included studies describing social engagement within the indica-
tor of leisure or mental activities12,13, however, one review defined “social networks” 
independently of leisure activities11. This review showed that much fewer studies have 
examined the relationship between a social network and risk of dementia (4 of the 51 
included studies)11. Again, the term social network is quite broad and within this descrip-
tion are a number of different indicators (e.g., number of confidants, marital status, living 
alone or satisfactory relationship with children or friends). Yet, all of the included studies 
reported associations between a greater social network and a reduced risk of dementia.
Premorbid intelligence and socioeconomic status
Two other potential indicators of cognitive reserve (premorbid intelligence and socio-
economic status) were also discussed in two reviews11,13, but the number of included 
studies for these indicators was more restricted (6 studies for socioeconomic status and 
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2 studies for premorbid IQ). One review article examining the concept of premorbid IQ 
(intelligence before dementia onset) only evaluated two studies, and found that higher 
premorbid intelligence was significantly associated with a reduced risk of dementia13.
One review examined socioeconomic status and dementia incidence11, but concluded 
that there was insufficient evidence of an association between socioeconomic status, at 
any stage of life, and risk of dementia. Although education is the most common measure 
for socioeconomic status, included studies encompassed many different definitions for 
socioeconomic status (e.g., father’s occupation or a mixture of schooling, occupational 
status and income). Results from the studies were inconsistent, with some suggesting a 
positive association between higher socioeconomic status and reduced risk of demen-
tia19,20, whereas other studies suggested the association was confounded by education, 
further, conflicting results were also found amongst studies investigating early-life 
socioeconomic status and risk of dementia21,22.
Overall effect of reserve indicators
Two of the included reviews examined the overall effect of brain reserve towards 
dementia incidence by combining the effects of multiple potential cognitive reserve 
indicators12,13. The first review looked at the effect of three reserve indicators (educa-
tion, occupation and mental activities), and found that overall high cognitive reserve 
was associated with decreased longitudinal cognitive decline12. The authors stated that 
this effect size was large and significant (φ=1.70, p<0.001), and the included studies 
controlled for a number of confounding factors. The most common confounding factors 
adjusted for included age and gender; however, multiple other confounding factors, 
such as disease history and physical function, were also adjusted for. Yet, studies dif-
fered widely as to how many and which confounding factors were adjusted for, with 
some studies not reporting any adjustments. The second review combined education, 
occupation, premorbid IQ and mentally stimulating leisure activities and found that 
higher reserve was associated with a reduced risk of incident dementia (OR=0.54, 95% 
confidence interval: 0.49 to 0.59)13.
DISCUSSIOn
Summary of findings
The most widely investigated potential indicators of the cognitive reserve hypothesis 
include education, occupation and leisure or mentally stimulating activities. Further, 
social engagement or social networks has been investigated both as their own indicator; 
separate from other mental activities, and in combination with other leisure activities. 
Reviews examining the cognitive reserve hypothesis have found that the majority of 
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current evidence indicates that higher educational attainment, occupation and regular 
participation in leisure and social activities are associated with a decreased risk of future 
dementia.
There appears to be less decisive evidence, as compared to education, that occupa-
tion is associated with reduced risk of dementia and, therefore, if this supplies cognitive 
reserve. Yet, occupation appears to overlap with some of the other indicators discussed 
in other reviews, such as extensive social networks or regular participation in intellectu-
ally stimulating activities.
Perhaps there is an inverse relationship between occupation and leisure time activ-
ity, such as those who are unemployed or retired may have more leisure time than 
those who are employed, which could affect results. Further, different leisure activities 
investigated seemed to be very diverse and included a wide-range of activities, such as 
participation in sport, daily gardening or travelling. Therefore, which leisure activities 
may have a greater positive effect on reducing the risk of dementia is not clear, and 
what specific aspects of these activities may be most beneficial (e.g., social, physical 
or mentally stimulating or a combination of these) also requires further clarification. A 
similar potential indicator of cognitive reserve was described as “regular participation in 
intellectually stimulating activities”10. Although, this review did not specifically use the 
term leisure activities there is obviously an overlap between any intellectually stimulat-
ing activities and leisure activities in terms of potential benefits to cognitive reserve. This 
demonstrates the issue of accurately defining indicators of cognitive reserve. Further 
indicators that have been investigated were premorbid intelligence and socioeconomic 
status, but few studies have been conducted for both of these indicators, and the find-
ings for the relationship between socioeconomic status and risk of dementia have been 
inconsistent11.
Studies that have combined multiple indicators of cognitive reserve have concluded 
that higher cognitive reserve is associated with a decreased risk of incident dementia, 
and this effect was large and significant12,13. Yet, it has been noted that it is difficult to 
distinguish if a higher reserve decreases the risk of dementia or only delays its onset11. 
This requires further investigation.
limitations of reviews
32 narrative reviews examining the cognitive reserve hypothesis were identified in 
our initial search. These were excluded from this review. In contrast, fewer systematic 
reviews or meta-analyses evaluating indicators of the cognitive reserve hypothesis have 
been conducted. Systematic reviews are important as they ensure that the evidence 
contained within the review summarizes the current available literature and are rep-
resentative of high-quality evidence. The indicators that were discussed in the reviews 
differed and there was also heterogeneity between included studies as to how they 
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categorized different reserve indicators (e.g., whether social and leisure activities were 
combined as one category).
Education, occupation and leisure activities have been more widely explored, and 
premorbid IQ and socioeconomic status were explored to a certain extent. However, 
the findings from neuroimaging studies were only systematically examined in one of 
the reviews, even though neuroimaging studies have provided important findings for 
the concept of cognitive reserve23. Indeed, neuroimaging studies have shown that for 
patients with Alzheimer’s disease with similar levels of dementia severity, higher years 
of education, occupational attainment and increased leisure activities is associated with 
lower levels of cerebral blood flow, a marker for Alzheimer’s pathology2. In addition, ani-
mal studies were excluded as the focus of this review was human studies. Animal studies 
have provided a great deal of information regarding cognitive reserve as such studies 
allow for greater control of the environmental factors which could influence cognitive 
reserve. Indeed, animal studies have shown that adult mice that have been exposed to 
an enriched environment have significantly more hippocampal neurons24 and reduced 
amyloid-β levels25. A recent review summarizes the current evidence gained from animal 
studies regarding the potential mechanisms of cognitive reserve towards Alzheimer’s 
disease and how it may affect neurogenesis, neuroplasticity and the locus coeruleus-
noradrenergic system26.
Other potential indicators that were identified within narrative reviews, that were not 
included in any of the systematic reviews, included: dietary habits27-29, personality indica-
tors30,31, prenatal environment32,33, childhood environment32,34 and genetic indicators33-35. 
Also, when exploring a model for cognitive reserve it should be noted that studies have 
suggested that alcohol consumption, substance abuse, social isolation and medical con-
ditions such as depression, anxiety, diabetes, hypertension and pulmonary disease may 
all lower cognitive reserve capacity26,27,32,36. The systematic reviews examining cognitive 
reserve or brain reserve found in this review did not include proxy measures for brain 
reserve capacity such as brain size, head circumference or neuronal count.
Article Quality
The systematic reviews investigated in this review were assessed using the AMSTAR tool 
and the quality of the majority of reviews was found to be low, with only one review 
meeting the criteria for moderate quality10. None of the reviews detailed the conflicts 
of interest of their included studies, assessed and documented the scientific quality of 
their included studies or provided a list of both their included and excluded studies. 
More high-quality systematic reviews examining the different indicators of cognitive 
reserve individually and as a combined effect would be beneficial.
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limitations of original studies
Included studies within the different reviews differed widely with regards to what cri-
teria were used for the indicators (e.g., how to define high vs. low education), and also 
how the indicator was measured (e.g., degree of literacy vs. number of years of educa-
tion). Further, there were differences as to what methods were used for analysis (e.g., 
cross-sectional or longitudinal design), and what confounding factors were controlled 
for (e.g., sex, age). Three of the five systematic reviews examined cross-sectional and 
longitudinal studies together, even though it is difficult to determine causal inference 
from cross-sectional studies. It was suggested in one review that the methods for analy-
sis and the differences in the design of the studies (e.g., populations used) were a major 
source of heterogeneity10. As well as variations in the independent indicator, there were 
many different cognitive outcome measures, effect size estimates and follow-up ranges. 
Therefore, the heterogeneity of the studies made comparing them difficult.
COnClUSIOnS
Current evidence suggests that education, occupation and leisure activities, with a 
social and mentally stimulating aspect, supply the cognitive reserve and offer a protec-
tive effect against the risk of dementia. However, other indicators may also supply the 
reserve, but research is lacking with regards to creating a full cognitive reserve model 
and determining the overall effect this has towards cognitive function and dementia. 
Further research is also needed to clarify how the different indicators may supply the 
cognitive reserve and offer a protective effect against dementia, a delay the onset of de-
mentia or influence the progression of dementia and cognitive symptoms. Determining 
the importance and relevance of cognitive reserve and the indicators which supply the 
reserve (e.g., modifiable indicators such as involvement with leisure activities) could 
lead to new intervention strategies to reduce the risk of dementia. Creating a set defini-
tion of the indicators of the cognitive reserve model, and further understanding which 
indicators are the most important for defining cognitive reserve, would be needed 
before testing possible interventions that may increase the reserve supply and hence 
the risk of dementia.
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ABSTRACT
Background Reliable quantification of the burden of stroke in low- and middle-income 
(LMI) countries is difficult as population-based surveillance reports are scarce and may 
vary considerably in methodology. We aimed to evaluate all available primary stroke 
surveillance studies by applying components of a benchmark protocol [World Health 
Organization (WHO) ‘STEP-wise’ approach to stroke surveillance] and quantify the ‘re-
ported’ burden of stroke in LMI settings.
Methods Electronic databases Medline, EMBASE, Scopus and Web of Knowledge were 
searched for population-based surveillance studies. Studies conducted in the LMI 
countries that reported on incident stroke were included. Data was extracted from each 
study using a pre-structured format. Information on epidemiological measures includ-
ing crude and age-adjusted incidence rates, person-years, admission rates, case fatality 
rates, death certification, autopsy rates, measures of disability and other study specific 
information, in line with WHO-STEPS-stroke protocol, were recorded. Age-adjusted inci-
dence rate data of stroke were combined using random-effects meta-analyses.
Results We identified seven studies that reported on burden of stroke in nine LMI 
countries, including aggregate information from 1,711,372 participants collected over 
5,240,923 person-years. The age-adjusted incidence rates across the LMI countries var-
ied widely, with the burden of total first-ever strokes ranging from 41 to 909 events per 
100,000 person-years.
Conclusions Systematic evaluation of all available primary surveillance studies, par-
ticularly in the context of WHO-STEPS guidelines indicate inadequate adherence to 
standardized surveillance methodology in the LMI countries. Incorporation of standard-
ized approaches is essential to enhance generalizability and estimate stroke burden 
accurately in these resource-poor settings.
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4.2
InTRODUCTIOn
Stroke remains a major cause of death and disability globally, claiming more lives each 
year than HIV-AIDS, tuberculosis and malaria put together1–3 and accounting for 46.6 
million Disability-adjusted life years (DALYs) worldwide.4 In 2005, mortality due to stroke 
was 5·8 million and more than 85% of all stroke-related deaths were estimated to occur 
in low- and middle-income (LMI) countries.5-8 Accurate estimation of stroke burden in 
these settings is difficult due to shortage of resources to establish sustainable, reliable 
and standardized surveillance systems essential to generate comparable data.
In this context, the World Health Organization (WHO) has devised a tool for stroke 
surveillance that comprises six modules arranged in three different ‘STEPS’ based on the 
initial presentation and outcome of a stroke patient.9 As the hierarchy of the modules 
is climbed, the costs and complexity of data collection processes increases. In LMI 
countries, where resources are limited the importance of seeking an optimum balance 
between feasibility and practicality is considered the mainstay of this system to gather 
stroke epidemiology data.9 Interpretation of available reports in LMI regions is also com-
plicated as data collection methods vary widely across studies. Systematic assessment 
of these studies, particularly in the context of the WHO surveillance guidelines, could 
potentially help (1) collect more reliable stroke estimates in LMI countries, (2) allow 
international comparisons across populations, and (3) shape public health interventions 
and policies aimed to improve the prevention and management of stroke.
Therefore, the purpose of this review is to: (1) systematically evaluate published stud-
ies on stroke surveillance in LMI countries in order to compare the strategies adopted 
by these studies with that of the stroke surveillance protocol proposed by WHO, and (2) 
quantify the burden of first-ever stroke in LMI countries reported in available studies 
from these settings.
METHODS
This review was conducted using a predefined protocol and in accordance to the PRISMA 
guidelines.
Search strategy
We conducted a systematic literature search to corroborate surveillance data and to 
identify candidate studies on stroke surveillance in low- and middle-income coun-
tries. A combination of controlled vocabulary and keywords were used in the search 
strategy in electronic databases: Medline, EMBASE, Scopus and Web of Knowledge and 
no restrictions were placed by date of publication. The search strategy was restricted 
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to English Language. Stroke surveillance registries were also searched for local data. 
The computer-based searches combined search terms related to the surveillance (e.g. 
“population surveillance”, “surveillance”, “sentinel surveillance”, “survey”), outcome (e.g. 
“stroke”, “cerebrovascular disease”) and LMI countries (eg, “low-and middle-income 
countries” and “names of all LMI countries individually (Appendix)”).
Study selection
Identification of LMI countries was based on World Bank groups by income per capita. 
Income categories used were for 2006-2010 according to Gross National Income (GNI) 
per capita.10 Studies were included that identified stroke as per WHO definition: a clinical 
syndrome characterized as “rapidly developing clinical signs of focal (at times global) 
disturbance of cerebral function, lasting more than 24 hours or leading to death with 
no apparent cause other than that of vascular origin”.9 Population-based surveillance 
studies recording incidence and case-fatality were included in this review. Selection 
of studies and full eligibility criteria are presented in Figure 1. We cross-referenced all 
papers selected to identify further relevant studies.
figure 1. Flow-diagram of literature search
23 studies excluded after application 
of the exclusion criteria:
• 3 Studies looking at TIA
• 4 Feasibility reports
• 7 Studies looking at risk 
factors for stroke
• 5 Reviews
• 4 Unavailable articles**
7 studies included in the review
Population-based stroke 
registries searched
Data base searched
Medline, EMBASE, 
Scopus and Web of 
Knowledge *
30 articles included after application of the inclusion 
criteria and full texts reviewed for eligibility: 
• Identied stroke as per WHO denition of 
stroke 
• Surveillance studies
• Studies investigating incidence, prevalence, 
and case fatality due to stroke
46 articles excluded 
by title and abstracts
that did not full the 
inclusion criteria
76 articles identied, de-duplicated and screened
* See Appendix
** Studies were not available in the archives and no contact with the authors was established to retrieve full texts.
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4.2
Data extraction
We extracted data from each study using a pre-structured format. Specific epidemio-
logical measures including crude incidence rates, person-years, age adjusted incidence 
rates, hospital admission rates, case fatality rates, death certification, autopsy rates and 
measures of disability were recorded. Incidence rates were age-standardized per 100000 
individuals by use of direct method using the WHO World Standard population11. Usage 
rates of MRI or CT scan in stroke diagnosis, determination of stroke subtypes and 
whether it was a first-ever or recurrent event were also extracted. We also recorded and 
compared the dates of publication, year in which surveillance was conducted, location, 
study duration, specific aims and the strengths and limitations of each study.
Application and comparison of STEPS Stroke surveillance criteria to each study
The WHO STEPS - stroke surveillance protocol9 employs three steps for stroke surveil-
lance as described below:
STEP 1. Events in the hospital: Gives frequency of hospital admissions due to stroke. It 
consists of three modules that obtain core data. Module 1 includes basic history of the 
patient and records whether it’s a first time or a recurrent stroke. Module 2 measures 
patient’s functional level and in-hospital medical treatment. Module 3 consists of utiliza-
tion of imaging facilities to classify the type of stroke.
STEP 2. Fatal events in the community: Enables calculation of mortality rates. This records 
the stroke events that result in fatality but do not reach the health facility. Information 
about these events is gathered from death certificates or verbal autopsies (Module 4). In 
countries where death certification is either not used routinely or uncertain in validity, 
verbal autopsies are used to ascertain the cause of death. Module 5 is the data collection 
from death records undergoing medical autopsies.
STEP 3. Non-fatal events in the community: Provides incidence rates and case-fatality. It 
represents the highest level of complexity in data collection. This involves medically rec-
ognizing all the stroke patients that are cared for entirely within the community and are 
not managed in the hospital at any time during or after the onset of stroke (Module 6).
Depending on the availability of resources, layers of information can be built upon the 
basic framework of these three steps adding detailed surveillance information in the 
form of modules.
The surveillance strategy and characteristics of each study were scrutinized and 
further divided to fit the guidelines proposed in the form of these three fundamental 
STEPS and various sub-modules of the WHO STEPS – stroke surveillance protocol. Even 
if the study was not based on the STEPS-protocol, we used it as a template by which the 
methodology of each study was compared (Supplementary table 1 and table 1).
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4.2
Statistical methods
Summary incidence rates (and corresponding 95% confidence intervals) were cal-
culated by pooling the study-specific estimates using a random-effects model that 
included between-study heterogeneity (parallel analyses used fixed-effect models). 
Heterogeneity of findings across studies was primarily assessed by standard χ2 tests 
and the I2 statistic.12. Additionally, further detailed assessments of heterogeneity were 
carried out by comparing results from studies sub-grouped according to different study 
characteristics using meta-regression technique, and by performing sensitivity analyses 
to evaluate the influences of selected study or characteristics on the overall results. All 
statistical tests were two-sided and used a significance level of p <0·05. All analyses were 
performed using Stata release 11 (StataCorp, College Station, Texas).
RESUlTS
Study selection and characteristics
The initial search yielded 76 articles, the titles and abstracts of which were reviewed, 
out of which 30 fit the inclusion criteria and were subjected to further review. After ap-
plication of inclusion and exclusion criteria to the full texts of these articles, we included 
a total of seven articles in this review (Figure 1). Their summary characteristics are pro-
vided in Supplementary table 1 and Table 1. According to the WHO regions, within the 
LMI countries, surveillance of stroke has been undertaken (and published) in Sri Lanka 
and India (South Asia);13 14 Ukraine, Georgia, and Bulgaria (Europe);15 16 18 Brazil (South 
America);17 Mongolia (Western Pacific);13 Nigeria (West Africa),13 and Tanzania (East 
Africa).19 Majority of the included studies were conducted primarily in urban popula-
tions with only two studies (Powles et al.18 (Bulgaria) and Walker et al.19 (Tanzania)) that 
included both urban and rural participants. Most studies restricted their study popula-
tion to 45-85 years age group in which most strokes typically occur (population at risk).
Comparison with wHO STEPS surveillance protocol
We applied the three-step WHO STEPwise approach (Figure 2) to optimize stroke surveil-
lance for LMI countries to individual studies (Supplementary table 1 and Table 1). All 
studies covered at least one part of the STEPS approach, but beyond that adherence 
to the STEPS protocol was patchy. Dalal et al.14 based in urban India was the only study 
that incorporated the STEPS-stroke exclusively as its operational protocol. All studies 
established surveillance sites at local hospitals. Although patient core data, functional 
assessment and medical treatment were recorded comprehensively, the majority of 
these studies were generally limited by resources or availability of neuro-imaging to ad-
equately classify and validate stroke subtypes. CT scanning rates varied substantially in 
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these studies (ranging from 0 to 100%). Minelli et al.17 was the only study that performed 
CT scan on all of its recruited participants. By contrast, Aho et al. state that they did not 
have any access to CT scan facilities to enroll imaging-confirmed strokes at any of the 
participating centers due to unavailability (Supplementary table 1 and Figure 4 ).13
All studies recorded one-month case fatality data and three13 17 19 followed up patients 
for six-month case fatality. While disability assessments were not adequately deter-
mined in the majority of studies, Minelli et al.17 and Dalal et al.14 were notable excep-
tions; they used Barthel scale for disease prognosis and Modified Rankin Scale (MRS) 
at day 28 to predict long-term disability respectively. (Death certification and autopsy 
figure 2. Descriptive protocol of an ideal stroke surveillance strategy adapted from WHO Stepwise ap-
proach to Stroke surveillance
± ±
± ±
STEP 1: Stroke patients admitted to the hospital
Patient 
presented with 
new stroke 
and diagnosed 
by a doctor
Reassessment of 
patient at 24 
hours of 
admission to 
dierentiate from 
TIA
Determine NIHS Score 
at 48 hours after 
admission to measure 
neurological decit
10 day case fatality
Vital status at day 10 
to cover most fatal 
complications
± imaging to classify 
stroke type (within rst 2 
weeks of admission)
Patients who suer 
stroke in the hospital 
or patients presented 
to the ER in a 
moribund state who 
die after admissionVital status at day 28 to 
include follow-up after 
discharge from the 
hospital. Modied 
Rankin Scale to assess 
functional independence
STEP 2: Fatal events in the community
Verbal autopsies Death certicates Medical autopsy
Vital statistics day 10-28
STEP 3: Non-fatal events in the community
GPs in an area to 
include in the 
surveillance activities
If the population is too 
large get a representative 
of GPs to assess the no. 
of cases managed over a 
dened period
Door to door survey of 
hemiplegia
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records were screened efficiently for mortality data in all studies. WHO-validated verbal 
autopsy method to ascertain fatal outcomes in LMI settings were employed by two stud-
ies.16 19 The most complex level of data collection for non-fatal events in the community 
remained a challenge in all included studies, although efforts were taken to contact 
local general practitioners and community health workers in some studies. The door-to 
door survey method, typically aiming to provide prevalence data of stroke, was used 
by Tsiskaridze et al.16 Walker et al.19 aimed to raise awareness of stroke, and potential 
preventative and treatment measures in the general population in order to enhance 
overall stroke recognition.
figure 3. Age adjusted incidence rates (95% CI) for incident stroke in low- and middle-income countries, 
based on available studies
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Random-effects meta-analyses of age-adjusted incidence rates in low-and middle-income countries included in this review.
Studies included in this meta-analysis collected stroke incidence data on all ages in their respective populations except for 
Bulgaria and Mumbai which were based on restricted age-bands. Age bands for each study: Ukraine: 0-45, 45-54, 55-64, 
65-74, 75-84, >85; Georgia: 0-44, 45-54, 55-64, 65-74, 75-84, ≥ 85; Bulgaria: 45-54, 55-64, 65-74, 75-84; Brazil: <45, 45-54, 
55-64, 65-74, ≥75; India (Rohtak): ≤ 44, 45-54, 55-64, 65-74,≥75; India (Mumbai) 25-34, 35-44, 45-54, 55-64, 65-74, 75-84, 
85->94; SriLanka: ≤ 44, 45-54, 55-64, 65-74,≥75; Mongolia: ≤ 44, 45-54, 55-64, 65-74,≥75; Tanzania:0-44, 45-54, 55-64, 65-74, 
75-84, ≥85; Nigeria: ≤ 44, 45-54, 55-64, 65-74,≥75.
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Burden of stroke in lMI countries
In aggregate, included studies in this review involved 3,113 incident stroke events col-
lected over 5,240,923 person-years from 1,711,372 participants. While all seven studies 
investigated the incidence of first-ever stroke (Figure 3 and Supplementary figure 1) 
only two13 19 provided additional data on recurrent stroke events. Based on WHO global 
regions, age-adjusted stroke incidence rates are presented in figure 3 and table 1. Only 
two studies gathered surveillance data differentiating between urban and rural set-
tings.18,19 The age adjusted incidence rates were approximately three times higher in the 
urban population of Tanzania (315·9 per 100,000 person-years) than the rural population 
(108·6 per 100,000 person-years). By contrast, in Bulgaria, stroke incidence estimate in 
the urban residents was almost half (919 per 100,000 person-years) compared to their 
rural counterpart (1576 per 100,000 person-years). Combined age-adjusted incidence 
rate, based on all nine LMI countries, was 165·8 per 100,000 person-years (Figure 3). 
Upon removal of the estimates from Bulgaria (ie, the only study based on restricted age 
bands) in the sensitivity analyses, the age-adjusted incidence rate was reduced to 100.45 
per 100,000 person-years (Supplementary figure 1). There was evidence of substantial 
heterogeneity across studies in both main and sensitivity analyses (I- squared esti-
mates >50% and P <0.001). In the subsequent subgroup analyses, conducted to explain 
the observed overall heterogeneity, there were important differences in the estimates 
across several study level characteristics. For instance, studies published after 2005 (i.e. 
year when WHO-STEPS was formally operationalized), studies that had lower hospital 
admissions, those that had lower case fatality and higher CT/MRI autopsy proportions 
tended to have significantly higher stroke incidence rates (metaregression P<0·05 for all; 
Supplementary figure 2).
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DISCUSSIOn
This comparative review is the first attempt to systematically compare the methodology 
used across published primary reports of stroke surveillance studies. In context of the 
WHO STEPS stroke surveillance protocol as a benchmark approach especially in the low- 
and middle-income countries revealed a lack of standardized approach towards stroke 
surveillance. Additionally, evidence from these population-based surveillance studies 
showed that the apparent discordance in the burden of incident stroke events across 
the LMI countries can be due to inherent differences in the population groups involved 
and potentially to the large variations in the underlying methods used. For instance, the 
age-adjusted rate of new stroke events in Bulgaria was much higher than that of other 
countries. It is possible that this resulted from an apparent “hot pursuit” nature of this 
study that adopted a more vigorous approach and restricted age bands.
Furthermore, our subgroup analyses provide further support towards the potential 
role of heterogeneity between the studies that might affect the true disease burden 
estimates of stroke in the LMI countries. It is likely that the burden of stroke is under-
estimated in the LMI countries, as there have been few large-scale systematic efforts 
to monitor the actual occurrence of cerebrovascular diseases in these settings. Limited 
numbers of nationally-representative surveys, lack of adherence to standardized opti-
mum protocols, and limited disability information in the LMI countries have meant that 
conventional disease burden estimates have had to be derived from statistical modeling 
studies.20 21 Ability to accurately quantify the disease and causative risk factors for stroke 
will make the development of locally appropriate prevention and treatment strategies 
easier to shape and the data collected more reliable.
In our review, most primary LMI countries studies only recorded hospital morbidity 
and mortality of acute stroke, which makes accurate estimation of the burden of disease 
at a population level difficult. While hospital based data collection has shown to be 
feasible and easy to accrue in the LMI nations7, their interpretation can only be used to 
characterize patients who were admitted to a specific health facility. Hospitalization rates 
in LMI countries differ due to access barriers and hospital patient samples may not be 
representative of the population. These rates vary among urban and rural populations, 
and between countries - making meaningful comparisons difficult to achieve. Hospital-
based studies are also more likely to under-diagnose minor strokes. Linking up hospital 
events to death certificates in order to record cause-specific mortality is another chal-
lenge in LMI countries, as the majority of these countries do not have comprehensive 
certification of death. The data that are available are difficult to use for cross-national 
comparison since they often use different methods, varying criteria, and time periods.
Disability remains an important attribute resulting from cerebrovascular disease and 
has enormous economic implications.21 DALYs provide a useful indication of economic 
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and social burden of the disease as this records both morbidity and mortality.23-25. Several 
measures of disability assessment such as in-hospital disability scales (NIH Stroke Scale, 
and Glasgow coma scale) and post-acute event disability scales (Barthel index and MRS) 
have been formulated which provide disability scales encompassing the time of stroke 
onset and admission to the health care facility till the time of discharge and long term 
disability ascertainment. In future studies attention should be paid to inclusion of DALYs 
along with mortality and case fatality estimates.
It is well established that the rising burden of stroke in the LMI countries poses a 
high economic burden on the society as the event is typically followed by an array of 
expensive diagnostic measures, long hospital stays and often requires long-term reha-
bilitation.26 One method to estimate this associated financial burden is through Cost of 
Illness studies (COIs).27 COIs use prevalence and incidence data from surveillance studies 
to compose models in estimating costs. An earlier review estimated economic losses in 
23 LMI countries to be approximately $84 billion in economic output in 2006-2015 from 
coronary disease, stroke and diabetes combined.28 However, no such study is currently 
available to quantify economic losses attributed to stroke alone. Therefore, accurate 
cerebrovascular disease burden estimation (a prerequisite for reliable economic assess-
ment) would help inform health policy in the LMI countries.
Strengths of our study include its systematic approach. Additionally, we relied 
exclusively on “nationally conducted” population-based surveillance studies that use 
“reported” (rather than “estimated” national data from the global burden of disease 
study) data that gives a more indubitable reflection of the actual burden of stroke in 
LMI countries. We have included studies that conducted national surveillances of stroke 
in their representative population subsets that varied considerably in methodology, 
outcomes ascertained and population settings. Some limitations merit careful consider-
ation: As countries have gone through economic metamorphoses in the past decades, 
e.g. Russia, there may be some discrepancies between their current economic status and 
their status at the time the study was conducted. In order to minimize the disconformi-
ties we adhered to the categorization of the economic status of countries according 
to the 2006-2010 World Bank classification10. In our study, comparison has been made 
with the WHO STEPS stroke surveillance protocol as an operational guideline to collect 
stroke surveillance data in the LMI settings; however, there are other processes such as 
census data, from which burden of stroke can also be ascertained that could have not 
been sufficiently covered by the search strategy implemented in our review and limited 
the scope of our findings.
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COnClUSIOn
This study systematically evaluates the methodology protocols adopted for stroke 
surveillances and compared the available surveillance studies to generate an overall 
comparative scenario. Available literature generally indicates lack of standardized 
surveillance systems in low-and middle-income countries. Although, primary surveil-
lance studies have been conducted in most global regions, they remain difficult to be 
compared across nations or regions due to heterogeneity in underlying methodologies. 
If a more standardized benchmark approach for stroke surveillance was adopted, better 
estimates of the current and future burden of stroke would become available, which 
could inform future health policy. As resources are limited in LMI countries it might be 
considered to focus on establishing sustainable systems to gather reliable and accurate 
data on stroke mortality and risk factors shared by other non-communicable diseases. 
Wider application of comprehensive and practical, yet feasible surveillance protocols 
such as WHO-STEPS-stroke could potentially maximize available local resources and 
produce comparable data to help shape effective stroke reduction programs and poli-
cies in resource-poor settings.
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SUPPlEMEnTARy MATERIAl
Supplementary figure 1. Age adjusted incidence rates (95% CI) for incident strokes in low- and middle-
income countries, based on available studies
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Supplementary Material 
Overall* 
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Mongolia
Country
Brazil
India  (Mumbai)
Ukraine
140,926 
124,700
2,409,300
56,447
783,900
Total 
person-years 
75,053 
313,722
125,482
233
82
300
157
653
No. of stroke 
events 
81
456
352
100.45 (62.54, 161.40)
103.00 (75.78, 139.99)
315.90 (282.43, 353.34)
48.00 (38.52, 59.81)
41.00 (36.67, 45.84)
108.60 (89.55, 131.71)
78.00 (71.71, 84.84)
Incidence rate (95% CI) 
130.00 (97.99, 172.46)
151.00 (137.59, 165.71)
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Figure e-1. Age adjusted incidence rates (95% CI) for incident strokes in low- and middle-income countries, based on 
available studies
10 25 50 100 250 500 
Age adjusted incidence rate per 100,000 person-years 
4,,591,930 2,477 
From random-effects meta-analyses; * Based on 6 studies and excluding Bulgaria; U, urban; R, rural; P for I- squared estimate <0.001  
From random-effects meta-analyses; * Based on 6 studies and excluding Bulgaria; U, urban; R, rural; P for I- squared esti-
mate <0.001
Supplementary figure 2. Age-adjusted incidence rates (95% CI) for incident stroke in low- and middle-
income countries, by different subgroups
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Publication year 
Average hospital admission (%) 
Case fatality proportion (%) 
CT/ MRI autopsy proportion (%) 
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343.65 (319.27, 369.89)
Figure e-2. Age-adjusted incidence rates (95% CI) for incident stroke in low- and middle-income countries, by different subgroups 
Meta-regression P <0.05 for all subgroups; * year when WHO-Steps was formally introducedMeta-regression P <0.05 for all subgroups; * year when WHO-Steps was formally introduced
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Appendix. Search terms and names of low income and lower-middle income coun-
tries included as headings in the literature search in accordance with world Bank’s 
criterion for classifying economies as per gross national income (gnI) per capita.1
Published studies were identified through electronic searches limited to the English 
language using MEDLINE, EMBASE, Scopus and Web of Knowledge databases. Electronic 
searches were supplemented by scanning reference lists of articles identified for all 
relevant studies (including review articles), by hand searching of relevant journals and 
by correspondence with study investigators. Published reports of local stroke registries 
were also searched for.
(i) MEDLINE strategy to identify relevant exposures and outcomes:
(“stroke”[Mesh] OR “cerebrovascular disorders”[Mesh] OR (“population 
surveillance”[Mesh] OR “surveillance”[All Fields] OR “sentinel surveillance[All fields]” OR 
survey”[All Fields] ) AND (“countries names”* OR “Low and Middle Income countries”)
Each term was specifically translated for searching alternative databases.
Below is the list of all the countries’ names that were used in the search strategy with 
“OR” in between in each country name.
lOw-InCOME COUnTRIES
Afghanistan, Bangladesh, Benin, Bhutan, Burkina Faso, Burundi, Cambodia, Cameroon, Central African Republic, 
Chad, Comoros, Congo, Côte d’Ivoire, Democratic People’s Republic of Korea, Democratic Republic of the 
Congo, Eritrea, Ethiopia, Gambia, Ghana, Guinea, Guinea-Bissau, Haiti, India, Kenya, Kyrgyzstan, Lao People’s 
Democratic Republic, Lesotho, Liberia, Madagascar, Malawi, Mali, Mauritania, Moldova, Mongolia, Mozambique, 
Myanmar, Nepal, Nicaragua, Niger, Nigeria, Pakistan, Papua New Guinea, Rwanda, Sao Tome and Principe, 
Senegal, Sierra Leone, Solomon Islands, Somalia, Sudan, Tajikistan, Timor-Leste, Togo, Uganda, United Republic 
of Tanzania, Uzbekistan, Viet Nam, Yemen, Zambia, Zimbabwe
lOwER-MIDDlE InCOME COUnTRIES
Albania, Algeria, Angola, Armenia, Azerbaijan, Belarus, Bolivia, Bosnia and Herzegovina, Brazil, Bulgaria, 
Cape Verde, China, Colombia, Cuba, Djibouti, Dominican Republic, Ecuador, Egypt, El Salvador, Fiji, Georgia, 
Guatemala, Guyana, Honduras, Indonesia, Iran (Islamic Republic of ), Iraq, Jamaica, Jordan, Kazakhstan, Kiribati, 
Maldives, Marshall Islands, Micronesia, Morocco, Namibia, Paraguay, Peru, Philippines, Romania, Samoa, Serbia 
and Montenegro, Sri Lanka, Suriname, Swaziland, Syrian Arab Republic, Thailand, The former Yugoslav Republic 
of Macedonia, Tonga, Tunisia, Turkmenistan, Ukraine, Vanuatu, West Bank and Gaza Strip
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In this chapter, I discuss the main findings of our research on cognitive outcomes in dif-
ferent populations along with methodological issues. Furthermore, I present the clinical 
implications of findings and considerations for future research.
MAIn fInDIngS
Breastfeeding
The World Health Organization (WHO) recommends six months of exclusive breastfeed-
ing as a global public health goal for infant’s overall health and wellbeing.1,2 Benefits 
of breastfeeding vs. formula feeding have been shown for infant diarrhea, otitis media, 
respiratory diseases and insulin dependent diabetes mellitus.3,4 However, results of 
studies examining the association of breastfeeding duration with cognitive develop-
ment are still strikingly inconsistent. Anderson et al. concluded in a meta-analysis that 
reported IQ differences favor breastfeeding over formula feeding.5 On the contrary, in a 
recent review, Kramer et al. concluded that there were no advantages in child cognition 
in children exclusively breastfed for 6 months; neither compared to children breastfed 
partially for 6 months nor compared to children with shorter than 6 months of breast-
feeding duration. Results were similar for developed and developing countries.1,6 One of 
the explanations of this controversy has been confounding of the association between 
breastfeeding and cognitive outcomes by factors such as maternal intelligence and so-
cioeconomic status. These factors not only affect cognitive performance of the child but 
also the mother’s decision whether or not to breastfeed. Additionally, some studies did 
not address questions of duration of breastfeeding, making the dose-response relation 
difficult to assess.7 Finally, formula milk has been fortified with long chain polyunsatu-
rated fatty acids in the last ten years, the composition of which mimics breast milk very 
closely. Studies comparing fortified formula milk to breast milk are, however, scarce. In 
Chapter 2.1, we describe the associations between breastfeeding duration and child 
non-verbal IQ attenuate after adjusting for various confounders. Our study is one of a 
few that prospectively assesses breastfeeding throughout the first year of life, thereby 
eliminating potential recall bias. Furthermore, we were able to adjust our analysis for 
maternal diet. It has been argued that LCPUFA content of maternal milk is dependent on 
maternal diet;8 with higher quantities reported in mothers who adhere to “healthy diet”. 
Previously, many studies have chosen fish intake and maternal folate levels as markers 
for maternal health reporting beneficial effects on the associations between breastfeed-
ing and child cognitive development.9,10 Our adjustment for maternal dietary patterns 
did not affect the results. However, since the availability of maternal dietary patterns 
was only limited to mothers of Dutch origin, these results cannot be generalized to 
other ethnicities and thus should be interpreted with caution. In light of these findings, 
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we conclude that the association between longer breastfeeding duration (regardless of 
exclusivity) and child IQ is confounded by maternal intelligence and sociodemographic 
factors such as maternal age, maternal BMI, parental education, and family functioning.
Arterial stiffness and blood pressure
It is well established in previous lines of research that cardiovascular markers are pri-
mary modifiable risk factors that affect cognitive outcomes in the elderly with particular 
emphasis on cognitive decline.11 Arterial stiffness is of particular interest because it is an 
easy measure of structural and functional changes in the vessel wall.12 Arterial stiffness 
is also related to hypertension and both are risk factors for cognitive decline and de-
mentia.13,14 These cardiovascular risk factors may have their correlates of subtle vascular 
damage very early in life which may affect late-life health, in our case late-life cognition. 
In Chapter 2.2, we tested whether arterial stiffness, measured by carotid-femoral pulse-
wave velocity and blood pressure affect cognition in early life. We found no evidence 
for an association between arterial stiffness and child IQ at age 6 years. A negative as-
sociation between diastolic blood pressure and child non-verbal IQ was observed that 
attenuated after adjustment for maternal factors. We concluded that the association of 
cardiovascular risk factors with child IQ is not evident in early age.
In the elderly, we simultaneously investigated the association between arterial stiff-
ness, blood pressure and general cognitive factor (g-factor)15. Next to higher age being 
known as the strongest risk factors for cognitive impairment, arterial stiffness was also 
suggested to be an early marker of subclinical vascular damage with high predictive 
accuracy.16 Previous literature highlights that the association between vascular risk fac-
tors, particularly blood pressure and cognitive impairment may differ for the very old 
(>75 years) and the young-old (<75 years).17,18 It is therefore important to distinguish 
between the young-old and the old-old, given differences in prevalence and risk of 
disease comorbidity, frailty, sensory and motor disabilities, cognitive impairment and 
dementia between the two groups.
In our study, we found that each unit increase in arterial stiffness as measured by 
carotid-femoral pulse-wave velocity is associated with a 0.40 decline in g-factor in the 
fully-adjusted model. This association observed is primarily driven by elderly <75 years 
old. For persons >75 years we found no association between arterial stiffness and g-
factor. We observed similar associations between systolic blood pressure and g-factor. 
The associations between diastolic blood pressure and g-factor in persons <75 years old 
attenuated after adjusting for education, BMI, smoking, diabetes and blood pressure 
lowering medication.
These findings highlight that accumulation of subclinical vascular risk factors through-
out the ageing process are responsible for cognitive changes in late life. We were not 
able to track their basis into early childhood.
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Subjective well-being and mortality
The vast majority of literature related to clinical research is based upon objective mea-
sures to assess health and well-being. However, recent evidence has pinpointed that 
subjective indicators of well-being are of equivalent importance as objective measures 
in the assessment of health outcomes.19 We conceptualised subjective well-being as 
a continuum consisting of parameters of physical functioning at one end and mental 
well-being at the other. We included basic activities of daily living, which is a subjective 
indicator of locomotive health, and instrumental activities of daily living that takes into 
account the cognitive attributes of performing daily tasks. Together, they cover a large 
aspect of overall physical and cognitive functioning. Mental health was conceptualized 
as a combination of somatic symptoms (i.e. physical manifestations of depression), 
negative affect and positive affect. Finally, quality of life is studied as a measure of 
subjective well-being that aims to bridge the physical and mental attributes of overall 
well-being. In chapter 3.1 we aimed to determine whether various measures of subjec-
tive well-being are associated with all-cause mortality.
We found that all measures of subjective well-being were related to mortality after 
adjustment for age, gender, education, cognition, prevalent chronic diseases (i.e. stroke, 
myocardial infarction, heart failure, diabetes, COPD, and joint problems), cardiovascular 
risk factors and lifestyle factors such as BMI, smoking and drinking. However, once 
mutual adjustment was carried out to determine the independent association of each 
measure of subjective well-being with mortality, we found that only impairment in 
self-reported BADL and IADL were independently related to all-cause mortality; QoL, 
somatic symptoms, negative affect and positive affect were not independently related 
to mortality after mutual adjustments.
Subjective memory and stroke
Cognitive impairment and dementia are well known to occur as a long-term conse-
quence of damage to the brain parenchyma after a stroke event.20 Stroke, cognitive 
impairment, and dementia share common vascular risk factors that influence each other 
in their pathogenesis.21 In light of this evidence, we aimed to determine the association 
between early cognitive impairment, which can present as subjective lapses in memory, 
and future risk of stroke in older persons.
In chapter 3.2 we found a higher risk of total stroke in persons who answered “yes” 
on the subjective memory complaints question than in persons who did not complain 
about their memory. We simultaneously investigated the association of an objective test 
of memory, the MMSE with the risk of stroke and found no significant associations. We 
scrutinized our data further by censoring participants in whom dementia developed 
during follow-up and excluded those who had an MMSE score lower than 26 at baseline 
to preclude that subclinical dementia may affect the association between subjective 
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memory complaints and stroke. We found similar results in these subgroups. In addition, 
we found significant interaction with education. Only in persons with a high vocational 
or university level of education, those who complained about their memory were at 
increased risk for stroke compared with persons who had no memory complaints.
These results highlight the significance of subjective memory complaints, especially 
in highly educated persons who may be protected by their cognitive reserve.22 Higher 
cognitive reserve may mask early cognitive changes that may have resulted from sub-
clinical vascular insults to the brain. Despite complaining about their memory, these 
persons may still perform well on objective cognitive tests. Therefore, complaints about 
memory in highly educated persons may be predictive of an increased risk of stroke.
Cognitive reserve
In clinical practice, the cognitive functional impairment in patients after enduring 
a stroke of a given magnitude can present in different ways; in some patients having 
profound impairment while in others producing minimal effects. This clinical phenom-
enon highlights that certain individuals endure neurodegenerative disorders that affect 
cognition such as stroke or dementia better than others. These differences in cognitive 
outcomes associated with similar brain pathology is hypothesized to be driven by the 
concept of cognitive reserve.23 Notwithstanding several attempts to produce a coher-
ent account of the concept of cognitive reserve, there is still lack of consensus in its 
definition. Previous lines of literature have proposed different ways to assess or measure 
cognitive reserve, but to date none has come to a conclusive recommendation.
In chapter 4.1 we attempted to pull together and review all available systematic re-
view literature on the concept of cognitive reserve through systematic literature search 
in seven databases. We identified five systematic reviews that incorporated findings 
from cohort, cross-sectional and case-control studies. Examined outcomes included 
Alzheimer’s disease, vascular dementia, non-specified dementia, all dementias and cog-
nitive decline or cognitive impairment. Education, occupation and leisure or mentally 
stimulating activities were suggested to supply cognitive reserve and offer a protective 
effect against the risk of dementia. Premorbid IQ and socioeconomic status have not 
been investigated as thoroughly and showed inconsistent results. Other indicators such 
as dietary habits and genetic indicators are understudied. Although it is shown that 
cognitive reserve has a protective effect against cognitive decline and dementia, the 
available research to date is insufficient to create a full cognitive reserve model.
Extrapolating cognitive outcomes to populations in low- and middle-income 
countries
Stroke is one of the most debilitating neurological diseases accounting for approximate-
ly 5.5 million deaths per year globally with a projected 61 million disability-adjusted 
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life years lost by 2020.24,25 85% of all stroke mortality is estimated to occur in low- and 
middle-income countries. Furthermore, the incidence rates of stroke in low- to middle-
income countries are estimated to exceed that in high-income countries.26 It is crucial 
to accurately estimate stroke burden in these low- and middle-income countries, both 
for risk factor identification, and to establish prevention strategies and health policies to 
reduce this burden. There is an urgent need for accurate and reliable stroke surveillance 
systems to generate comparable data. Also, existing population-surveillance systems of 
stroke in these low- and middle-income countries are scarce and vary in methodology. 
Therefore, in chapter 4.2, we conducted a systematic literature search and identified 
seven studies from nine low- and middle-income countries that reported the burden of 
stroke. We meta-analysed the data to report the age-adjusted incidence rates of stroke 
in order to determine the burden of first-ever stroke in these countries. We report 41 
- 909 first-ever stroke events per 100,000 person-years. Due to limited numbers of na-
tionally representative surveys, lack of adherence to standardized optimum protocols, 
and limited disability information in low- and middle-income countries, conventional 
disease burden estimates had to be derived from statistical modelling. We conclude that 
burden of stroke is underestimated in these countries, as there have been few large-
scale systematic efforts to monitor the actual occurrence of cerebrovascular diseases in 
these resource-poor settings.
METHODOlOgICAl COnSIDERATIOnS
Cognitive tests in different populations
With the rise in patients with dementia due to changes in the global age demographics, 
there is a clear need for valid and reliable cognitive tests that can be applied in popu-
lation studies on a large-scale. The large domain of cognitive function has previously 
been categorised into 1) crystallised abilities such as reading, general knowledge, and 
language abilities27, all of which are less likely to change with ageing and cognitive de-
terioration, and 2) fluid abilities such as memory, attention, and general cognitive speed 
that have a tendency to change with the ageing process or a disease state with clinical 
or sub-clinical cognitive changes.
The most commonly used objective measurement of cognitive function is the Mini 
mental state examination (MMSE).28 However, Houx et al.29 pointed that the MMSE 
includes many crystalline functions, which do not change much over time. Other draw-
backs are the fact that subtle improvements or deterioration over time are not captured 
in the over-all score. Moreover, subjects score higher on subsequently repeated tests, 
which hinders the reliability. We used the MMSE as well as a simple question on sub-
jective memory, i.e. “do you have memory complaints?” (yes/no), and associated these 
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measures with stroke. We found that MMSE was not associated with the risk of stroke 
while the subjective memory complaints were significantly associated. The importance 
of these results is two-fold: a) subjective health and health perception may be as impor-
tant as objectively measured health, and b) as discussed above, the use of MMSE may be 
disadvantageous in large-scale population studies. Other tests that are more sensitive 
to detect small changes in cognitive function in various domains should be employed. 
General cognitive factor (g-factor) is an example of such a test. In chapter 2.2 g-factor 
was utilised as a cognitive testing battery which constituted a colour-word interference 
subtask of the Stroop test, LDST, verbal fluency test, delayed recall score of the 15-WLT, 
and Purdue pegboard test. In its construct, g-factor utilizes the shared variance between 
individual cognitive tests, and can be interpreted as a common underlying factor to 
a variety of cognitive domains that is independent of each domain separately and is 
linked to general cognitive function or general intelligence.
In children, choosing tests to determine cognitive function is even more challenging. 
In early childhood, brain maturation and behaviour skills are developing simultaneously 
and synergistically. These processes are interactive and intertwined with each other and 
external environmental factors.30 Furthermore, infant and child cognition changes dra-
matically with age requiring several measurement tools of cognitive function across dif-
ferent age groups. For instance, several intelligence tests incorporate tests that require 
verbal output; whereas language development is largely different in a 2-year-old, when 
small sentence formation is the peak performance, or a 4-year-old, where vocabulary 
enhancement is the most crucial linguistic developmental milestone. Furthermore, in 
population studies with different ethnic groups who speak different languages, early 
childhood verbal tests cannot be implied without the risk of misclassification. On this 
basis, we chose to measure child IQ in chapter 2.1 using two subtests of a Dutch nonver-
bal intelligence test: the Snijders-Oomen Niet-verbale intelligentie Test–Revisie (SON-R 
2½ - 7)31 in children aged 6 years. This was designed to minimize the reliance on acquired 
knowledge and verbal ability. The test allows a scaled total score to be calculated for any 
combination of subtests with the same distribution characteristics as the IQ score. Two 
subsets were chosen for Generation R: Mosaics, which assesses spatial visualisation abili-
ties, and Categories, which assesses abstract reasoning abilities. In a different sample of 
626 children, aged 4.5–7.5 years, the correlation between the total scores derived from 
the Mosaics and Categories subsets, and the IQ scores derived from the complete test, 
was r = 0.86.32 For our study, raw test scores were converted into nonverbal intelligence 
scores using norms tailored to the child’s exact age.33 Using nonverbal IQ as our main 
outcome increases generalizability of our study results to different populations.
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Interaction
Interaction occurs when the effect of a determinant on the outcome is different across 
strata or the continuum of another variable, which can be both a background or risk fac-
tor. According to Rothman, there are two types of interaction: statistical and biological.34 
Statistical interaction can be assessed by adding a product term to the models used in 
the analysis. The interpretation of regression coefficients of this product term depends 
on the type of statistical model used. In linear regression, the regression coefficient of 
this product term is interpreted as departure from additivity, while in logistic regression 
and Cox regression the regression coefficient of the product term indicates the degree 
of departure from multiplicativity.
Biologic interaction is typically defined as the interdependent operation of two or 
more causes in the same causal model.35 Consider a simple hypothetical example – 
the causal model for the incidence of oesophageal cancer: smoking doubles the risk 
of oesophageal cancer while drinking alcohol triples the risk of oesophageal cancer 
(figure 1). Smoking and alcohol are both causes. They may act independently or may 
have a synergistic effect on the development of oesophageal cancer. The synergistic 
interdependence is subject to evaluation by assessment of interaction. In a multiplica-
tive model, interaction is evaluated as deviation from multiplicativity (deviation from 
the expected odds ratio (OR): 2 x 3 = 6); In an additive model, interaction is evaluated as 
deviation from additivity (deviation from the expected OR: 2 + 3 = 5). If the observed OR 
were 8, then the interaction is so strong and positive that it does not matter on which 
scale (multiplicative or additive) interaction is evaluated. If the observed OR were 5.5, 
this would suggest negative interaction on a multiplicative scale, i.e., smoking and 
drinking together would have less than the expected effect predicted for the incidence 
of oesophageal cancer on the basis of separate analyses. However, on an additive scale, 
this would suggest a slight positive interaction as the separate OR add up to OR = 5 
only. In etiologic epidemiology, biologic interaction should be considered by assessing 
interaction on an additive scale.34
In chapter 3.2, I tested interaction on a multiplicative scale to investigate whether 
education level affected the association between subjective memory complaints with 
the risk of stroke. I stratified the analysis on low, intermediate and high level of edu-
cation. This did not reflect an etiological concept but was “statistical default practice”. 
Alternatively, in the Cox proportional hazards model that I used in the analysis, interac-
tion on an additive scale could also have been considered. The interaction on the addi-
tive scale can be tested by either relative excess risk for interaction (RERI), attributable 
proportion due to additive interaction (AP) and synergy index (SI) with no additional 
assumption beyond those required for the Cox proportional hazard.36
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figure 1: Example showing the causal relationship of smoking and alcohol on the incidence of oesopha-
geal cancer.
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Figure 1: Example showing the causal relationship of smoking and alcohol on the incidence of 
oesophageal cancer. 
 
In chapter 3.2, I tested interaction on a multiplicative scale to investigate whether 
education level affected the association between subjective memory complaints with the risk of 
stroke. I stratified the analysis on low, intermediate and high level of education. This did not 
reflect an etiological concept but was “statistical default practice”. Alternatively, in the Cox 
proportional hazards model that I used in the analysis, interaction on an additive scale could 
also have been considered. The interaction on the additive scale can be tested by either relative 
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proportional hazard.36  
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For assessment of interaction on an additive scale, the simplest way is to calculate the 
Synergy Index (SI). SI is calculated as following:
 SI = Observed hazard ratio/Expected hazard ratio.
where observed is the HR for the joint effect of A and B (HR(AB)) and expected is obtained 
from the main effects of A and B as follows: [HR(A) + HR(B) – 1] under the assumption of 
additivity recommended in the STROBE statement.37 It is also suggested that reporting 
of P value of included product term for testing interaction is insufficient to evaluate 
departure from additivity when considering causal interaction effect.38
Based on the joint-effect results from the Cox model, I calculated the expected hazard 
ratios under the assumption of additivity using the original data used in chapter 3.2. 
We found that the association between subjective memory complaints and stroke was 
modified by the effect of educational level in the fully adjusted model. The strongest as-
sociation between subjective memory complaints and the risk of stroke were observed 
in the highly educated group. For ease of interpretability, I eliminated the intermediate 
education group from the education variable and will define the education variable 
dichotomously : “low education ” and “high education”. The hazard ratios for the associa-
tion with the risk of stroke which are as follows:
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 Education (high)/no subjective memory complaints (no) : HR= 1.05
 Education (low)/Subjective memory complaints (yes): HR= 1.07
 Expected HR under the assumption of additivity: 1.05 + 1.07 – 1 = 1.12
 Observed HR: 1.48
 Synergy Index (SI) = 1.48/1.12
  = 1.32
If the Synergy Index is different from 1, there is additive interaction. Therefore, in our 
study, we also observe additive interaction. This is analogous to the OR = 8 described in 
the example above. Thus, in our study, it does not matter on which scale interaction is 
tested; whether multiplicative or additive. The observed interaction is strong and posi-
tive beyond additive and multiplicative interaction.
Heterogeneity in meta-analysis
Meta-analysis is the statistical synthesis of results from individual studies aimed to 
integrate findings. A systematic review may be accompanied by a meta-analysis. In this 
thesis, we used systematic reviews to identify gaps in literature. In chapter 4.1 and 4.2 we 
conducted two systematic reviews in an attempt to identify all relevant studies fitting 
our predefined criteria; one of which also included a meta-analysis.
Meta-analysis provides a powerful tool to understand differences and similarities of 
results across multiple studies. Performing a meta-analysis involves: 1) calculation of a 
summary statistic for each included study and 2) combination of these summary statis-
tics into a weighted average.39 The aim was to summarize the validity and findings of the 
included studies which offers a more generalizable result than results of single studies.40 
However, the conclusions are less clear when the effects across the included studies are 
inconsistent. Consistency of effects across studies in a meta-analysis can be assessed by 
a statistical test of heterogeneity.41
Heterogeneity is encountered when summary statistics from different studies are 
pooled. Heterogeneity can be due to variations in study sample, outcomes, locations or 
differences in study design and measurements or a combination of any of the above.42 
There are various ways to deal with heterogeneity by statistical tests. We used I2 statistic 
that measures the proportion of the total statistical heterogeneity due to variation be-
tween studies rather than chance.43 It is also viewed as a measure of inconsistency across 
studies. The estimation of heterogeneity is useful because it is calculated as a percentage 
enabling comparison across meta-analyses. However, there is no fixed categorisation of 
heterogeneity; roughly 25%, 50% and 75% are defined as “low”, “moderate” and “high” 
heterogeneity. These categorisations are tentative and quantification and interpretation 
of variability across studies also depends upon clinical and methodological diversity in 
the included studies.41
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In chapter 4.2 we found substantial heterogeneity (>50%) across studies included in 
the meta-analysis. This is because all studies were conducted in different populations 
and differences were present in data collection and case identification of stroke across 
the included studies. We conducted a subgroup meta-analysis in order to stratify the 
studies and to explain the observed heterogeneity. We were able to deduce differences 
in the meta-analysed incidence rates of strokes on the basis of location, publication 
year, average hospital admission, case fatality proportion and CT/MRI autopsy propor-
tion. These findings point to gaps in stroke surveillance methodologies adopted by 
individual countries. Optimisation of stroke surveillance techniques may generate more 
comparable findings across different populations.
ClInICAl IMPlICATIOnS
Results from population-based observational studies like those presented in this thesis 
can provide insights upon shared risk factors for pathologies of cognitive function in 
different age groups. This may provide the window of opportunity to target specific 
groups in the general population for risk factor screening and further focusing primarily 
on risk factor reduction among the high-risk groups. Some conclusions drawn from the 
research of this manuscript have important clinical implications and are presented here:
The associations between risk factors for cognitive decline and dementia in the very-
old (>75 years) are not always consistent with those observed in the young-old (<75 
years). Pharmacological and non-pharmacological interventions to lower blood pres-
sure and/or to reduce arterial stiffness should be administered with caution in persons 
aged more than 75 years, as lower blood pressure and lower arterial stiffness do not 
necessarily translate to better cognitive function in very old persons. Current recom-
mendations to treat hypertension or maintain blood pressure at optimum levels are 
challenged by our findings and may be modified in order to target reduction in the risk 
of a cardiovascular event specifically in persons >75 years.
Early identification and modification of cardiovascular risk factors in persons who 
complain about their memory may help prevent future stroke, particularly in persons 
with a high level of education. In practice, simple screening by inquiring about subjec-
tive complaints about memory in older individuals during routine clinical examination 
may identify persons who are at higher risk for stroke. Once identified, these individuals 
may benefit from targeted interventions to reduce risk factors that are associated with 
stroke. Also it is important that caregivers should vigilantly monitor older persons, espe-
cially those who have attained a high level of education, about their memory status. If 
complaints about memory become evident, these persons should promptly be directed 
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to a general practitioner in order to assess their risk factor profile that may place them 
at a higher risk of stroke.
The degree of impairment in basic and instrumental activities of daily living may be 
used as screening tools to identify persons who are at a higher risk of death. Therefore, 
clinical and rehabilitative interventions aiming at improving survival could focus on ba-
sic and instrumental activities of daily living. Quality of life and symptoms of depression 
may be less optimal screening tools.
RECOMMEnDATIOnS fOR fUTURE DIRECTIOnS Of RESEARCH
Recommendations for cessation of research activity on the association 
between breastfeeding and IQ in children
Given the many studies on the association of breastfeeding with child IQ to date and 
the demonstrated huge confounding by maternal IQ, I recommend cessation of smaller 
studies within this field which do not take into account the important parental sociode-
mographic factors.
Recommendations for optimizing measurement of cognitive reserve
Longitudinal studies with large sample sizes will be important to further define cognitive 
reserve and its indicators. For comparison, studies should incorporate similar outcome 
measure and similar categorization and measurement of independent indicators. It is 
also important to explore optimization of measurement of cognitive reserve. Systematic 
reviews and meta-analyses may be helpful to thoroughly explore the different indicators 
of cognitive reserve that have been identified in single studies to date.
Recommendations for standardization of stroke surveillance protocols in low- 
and middle-income countries
Once a more standardized benchmark approach for stroke surveillance is adopted, bet-
ter estimates of the current and future burden of stroke would become available, which 
could inform future health policies. As resources are limited in low- and middle-income 
countries, I recommend to focus on establishing sustainable systems to gather reliable 
and accurate data on stroke mortality and risk factors shared by other non-commu-
nicable diseases. Moreover, I recommend applicability and adherence to WHO STEPS 
guidelines for stroke surveillance in these countries to generate comparable data. This 
helps not only to devise stroke reduction programs and policies but also to implement 
risk factor identification and reduction strategies. Clearly, the risk factor profile is differ-
ent in populations residing in these resource-poor settings than in the western world.
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COnClUSIvE REMARkS
The conclusions of this thesis offer a contribution to understanding developmental and 
degenerative aspects of cognitive outcomes in children and elderly respectively. Some 
associations observed have conveyed a profound public health message especially on 
the importance of subjective health. Hopefully, this thesis lays the foundation for future 
researchers to decipher epidemiological aspects of cognition across the life-course on 
a gradual scale. This could be made possible with the ongoing inclusion of participants 
at younger ages in the Rotterdam Study and the follow-up of Generation R children into 
adolescence.
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Summary
6
SUMMARy
When people age, accumulating diseases and biological changes may result in cogni-
tive deterioration. The degree of cognitive decline partly depends on early cognitive 
development. Several environmental and pathophysiological factors are assumed to be 
related to cognitive development in early life as well as to cognitive decline and survival 
in late life. The main aims of this thesis were 1) to extend existing knowledge on risk 
and protective factors of cognitive development in early childhood, and 2) to determine 
risk factors pertaining to subjective health and subclinical vascular disease that may be 
associated with cognitive outcomes and survival in late-life.
The studies in this thesis were conducted within two population-based studies in 
Rotterdam, the Netherlands; namely the Generation R Study,14 a children’s cohort from 
fetal life onwards and the Rotterdam Study,15 a prospective study among people of 45 
years and older.
In chapter 2.1, we studied the effect of longer duration of any or exclusive breast-
feeding in infancy on non-verbal IQ in children. We took several maternal and paternal 
life-style factors, socio-demographic factors, child factors and maternal IQ into account. 
Maternal IQ primarily accounted for the association between breastfeeding duration 
and child non-verbal IQ. Although breastfeeding may be beneficial for many health 
outcomes in children, we found no evidence for a direct effect of breastfeeding on non-
verbal IQ.
In chapter 2.2, we explored whether arterial stiffness and blood pressure affect child 
IQ or general cognition in an elderly population. Arterial stiffness and blood pressure 
were not associated to child IQ at age 6 years. However, arterial stiffness and systolic 
blood pressure were strongly associated with general cognition in the elderly up till 
age 75 years. These results suggest that subclinical vascular risk factors accumulate with 
increasing age which may affect cognition in late-life.
In chapter 3.1, we studied various measures of subjective well-being as predictors of 
all-cause mortality among the elderly. We found that subjective measures of physical 
and mental health strongly predicted mortality. Subjective measures of physical func-
tioning were independently related to mortality once we accounted for each measure of 
well-being in a mutually adjusted model.
In chapter 3.2, we investigated the association between subjective memory com-
plaints and the risk of stroke. Our results showed that subjective memory complaints 
were associated with a higher risk of stroke especially in persons with a higher level of 
education. Objective measures of cognition, such as the MMSE, was not related to the 
risk of stroke. These results suggest that subjective reports of health and well-being may 
be strongly associated with health outcomes.
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In chapter 4.1, we systematically reviewed literature on the concept of cognitive 
reserve and its operationalisation in the general population. From the existing body 
of literature on cognitive reserve, we conclude that education, occupation and leisure 
activities, with a social and mentally stimulating aspect, supply the cognitive reserve 
and offer a protective effect against the risk of dementia. Other indicators may also sup-
ply the reserve, but research is lacking with regards to creating a full cognitive reserve 
model and determining the overall effect on cognitive function and dementia.
In chapter 4.2, we systematically reviewed literature on methodologies adopted for 
stroke surveillance and meta-analyses incidence rates of stroke reported in previous 
studies conducted in low-and middle-income countries. Available literature suggests 
lack of standardized stroke surveillance systems in low and middle income countries. 
Against this background and a highly variable burden of stroke reported in previous 
studies, we propose adherence to the World Health Organization stepwise stroke sur-
veillance system for accurate and reliable collection of stroke surveillance data in low 
and middle income countries.
In chapter 5, the main findings of the studies in this thesis are summarized, together 
with their methodological considerations. This chapter is concluded with some clinical 
implications and suggestions for future directions for research.
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6
SAMEnvATTIng
Met het ouder worden kan de optelsom van ziektes en biologische veranderingen 
leiden tot verslechtering van het cognitief functioneren. De mate en snelheid van cog-
nitieve achteruitgang hangt mogelijk deels af van de vroege cognitieve ontwikkeling in 
de kindertijd. Diverse omgevingsfactoren en pathofysiologische factoren lijken zowel 
gerelateerd aan cognitieve ontwikkeling in het begin van het leven als aan cognitieve 
achteruitgang en overleving in het latere leven. Dit proefschrift had tot doel om 1) 
bestaande kennis van risico- en beschermende factoren van cognitieve ontwikkeling in 
de vroege kindertijd uit te breiden, en 2) om risicofactoren als subjectieve gezondheid 
en subklinische vasculaire ziekte te relateren aan cognitieve uitkomsten en overleving 
in het latere leven.
De studies in dit proefschrift werden uitgevoerd in twee populatiecohorten in 
Rotterdam, namelijk in de Generation R studie,14 een kindercohort gevolgd vanaf de 
intrauteriene fase, en in de Rotterdam Study,15 een cohort studie bij mensen van 45 jaar 
en ouder.
In hoofdstuk 2.1 bestudeerden we het effect van borstvoeding in het eerste levens-
jaar op non-verbaal IQ op de leeftijd van 6 jaar. Bij het onderzoeken van deze relatie 
hielden we rekening met verschillende leefstijlvariabelen gemeten bij vader en moeder, 
sociaaldemografische factoren, kind factoren en IQ van moeder. We vonden dat IQ van 
moeder de belangrijkste factor was die de associatie tussen de duur van borstvoeding 
en non-verbaal IQ bij kinderen kon verklaren. Hoewel borstvoeding waarschijnlijk vele 
gunstige gezondheidseffecten heeft, vonden wij dus geen bewijs voor een direct effect 
van borstvoeding op non-verbaal IQ.
In hoofdstuk 2.2 onderzochten we of vaatwandstijfheid en bloeddruk van invloed 
waren op IQ op de kinderleeftijd en/of algemene cognitie in een oudere populatie. We 
vonden geen bewijs voor een associatie tussen vaatwandstijfheid en bloeddruk ener-
zijds en IQ op de leeftijd van 6 jaar anderzijds. Wel vonden we sterke verbanden van 
vaatwandstijfheid en systolische bloeddruk met algemene cognitie bij ouderen tot de 
leeftijd van 75 jaar. Deze resultaten suggereren dat subklinische vasculaire risicofactoren 
met oplopende leeftijd in toenemende mate de cognitie kunnen beïnvloeden.
In hoofdstuk 3.1 bestudeerden we diverse subjectieve maten en constructen van 
welzijn als voorspellers van mortaliteit bij ouderen. We vonden dat mortaliteit voorspeld 
kan worden door subjectieve rapportages van zowel lichamelijke als geestelijke gezond-
heid. Alleen subjectieve rapportages van fysiek functioneren werden onafhankelijk in 
verband gebracht met mortaliteit.
In hoofdstuk 3.2 onderzochten we de relatie tussen subjectieve geheugenklachten 
en het risico op beroerte. Onze resultaten laten zien dat subjectieve geheugenklachten 
worden geassocieerd met een hoger risico op beroerte, vooral bij personen met een 
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hoger opleidingsniveau. Objectieve metingen van cognitie, zoals de MMSE, konden 
daarentegen niet gerelateerd worden aan het risico op een beroerte. Deze resultaten 
suggereren dat persoonlijke rapportages over gezondheid en welzijn mogelijk sterk 
geassocieerd zijn met gezondheidsuitkomsten.
In hoofdstuk 4.1 hebben we in een systematische review de literatuur over het con-
cept ‘cognitieve reserve’ en de operationalisering in de algemene bevolking beschreven. 
We concludeerden dat opleiding, beroep en vrijetijdsactiviteiten, via een sociaal en 
mentaal stimulerende werking, de cognitieve reserve bepalen en een beschermend 
effect tegen het risico van dementie bieden. Ook andere indicatoren dragen bij aan 
de cognitieve reserve, maar het onderzoek is nog onvoldoende om te komen tot een 
volledig ‘cognitieve reserve’-model en het bepalen van het totale effect daarvan op 
cognitieve functies en dementie.
In hoofdstuk 4.2 beschreven we systematisch de literatuur over methodes voor 
het herkennen en signaleren van beroerte en de meta-analyseerden wij de incidentie 
van beroerte zoals gerapporteerd in eerdere studies uitgevoerd in lage en midden 
inkomens landen. De beschikbare literatuur suggereert een gebrek aan gestandaardi-
seerde beroerte-surveillancesystemen in lage en midden-inkomenslanden. Tegen deze 
achtergrond en de hoge mate van variabiliteit in beroertelast, stellen wij voor om het 
stapsgewijze beroerte surveillance systeem van de World Health Organization (WHO) 
na te leven.
In hoofdstuk 5 worden de belangrijkste bevindingen van de studies in dit proefschrift 
samengevat, samen met hun methodologische overwegingen. Dit hoofdstuk wordt 
afgesloten met een aantal klinische implicaties en suggesties voor toekomstige richtin-
gen van onderzoek.
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